<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
<journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLoS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26580071</article-id>
<article-id pub-id-type="pmc">4646284</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0142831</article-id>
<article-id pub-id-type="publisher-id">PONE-D-15-27314</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Human <italic>MAMLD1</italic> Gene Variations Seem Not Sufficient to Explain a 46,XY DSD Phenotype</article-title>
<alt-title alt-title-type="running-head">Role of <italic>MAMLD1</italic> in 46,XY DSD</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Camats</surname>
<given-names>Núria</given-names>
</name>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Fernández-Cancio</surname>
<given-names>Mónica</given-names>
</name>
<xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Audí</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mullis</surname>
<given-names>Primus E.</given-names>
</name>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moreno</surname>
<given-names>Francisca</given-names>
</name>
<xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>González Casado</surname>
<given-names>Isabel</given-names>
</name>
<xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>López-Siguero</surname>
<given-names>Juan Pedro</given-names>
</name>
<xref ref-type="aff" rid="aff005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Corripio</surname>
<given-names>Raquel</given-names>
</name>
<xref ref-type="aff" rid="aff006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bermúdez de la Vega</surname>
<given-names>José Antonio</given-names>
</name>
<xref ref-type="aff" rid="aff007">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Blanco</surname>
<given-names>José Antonio</given-names>
</name>
<xref ref-type="aff" rid="aff008">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Flück</surname>
<given-names>Christa E.</given-names>
</name>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001">
<label>1</label>
<addr-line>Pediatric Endocrinology and Diabetology, Department of Clinical Research, University Children’s Hospital Bern, Bern, Switzerland</addr-line>
</aff>
<aff id="aff002">
<label>2</label>
<addr-line>Pediatric Endocrinology Research Unit. Vall d’Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, CIBERER (Center for Biomedical Research on Rare Diseases), Instituto de Salud Carlos III, Barcelona, Spain</addr-line>
</aff>
<aff id="aff003">
<label>3</label>
<addr-line>Pediatric Endocrinology, Hospital Infantil La Fe, Valencia, Spain</addr-line>
</aff>
<aff id="aff004">
<label>4</label>
<addr-line>Pediatric Endocrinology, Hospital Universitario La Paz, Madrid, Spain</addr-line>
</aff>
<aff id="aff005">
<label>5</label>
<addr-line>Pediatric Endocrinology, Hospital Materno-Infantil, Málaga, Spain</addr-line>
</aff>
<aff id="aff006">
<label>6</label>
<addr-line>Pediatric Endocrinology, Corporació Parc Taulí, Hospital de Sabadell, Sabadell, Spain</addr-line>
</aff>
<aff id="aff007">
<label>7</label>
<addr-line>Pediatric Endocrinology, Hospital Universitario Virgen Macarena, Sevilla, Spain</addr-line>
</aff>
<aff id="aff008">
<label>8</label>
<addr-line>Pediatric Urology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain</addr-line>
</aff>
<contrib-group>
<contrib contrib-type="editor">
<name>
<surname>Palit Deb</surname>
<given-names>Swati</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"></xref>
</contrib>
</contrib-group>
<aff id="edit1">
<addr-line>Virginia Commonwealth University, UNITED STATES</addr-line>
</aff>
<author-notes>
<fn fn-type="COI-statement" id="coi001">
<p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: NC MF-C LA CEF. Performed the experiments: NC MF-C. Analyzed the data: NC MF-C LA CEF. Wrote the paper: NC CEF. Contributed with the patients' data: PEM FM IGC JPL-S RC JABV JAB.</p>
</fn>
<corresp id="cor001">* E-mail: <email>christa.flueck@dkf.unibe.ch</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>11</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>10</volume>
<issue>11</issue>
<elocation-id>e0142831</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>6</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>10</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>© 2015 Camats et al</copyright-statement>
<copyright-year>2015</copyright-year>
<copyright-holder>Camats et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="pone.0142831.pdf" xlink:type="simple"></self-uri>
<abstract>
<p>
<italic>MAMLD1</italic> is thought to cause disordered sex development in 46,XY patients. But its role is controversial because some <italic>MAMLD1</italic> variants are also detected in normal individuals, several <italic>MAMLD1</italic> mutations have wild-type activity in functional tests, and the male <italic>Mamld1</italic>-knockout mouse has normal genitalia and reproduction. Our aim was to search for <italic>MAMLD1</italic> variations in 108 46,XY patients with disordered sex development, and to test them functionally. We detected <italic>MAMDL1</italic> variations and compared SNP frequencies in controls and patients. We tested MAMLD1 transcriptional activity on promoters involved in sex development and assessed the effect of MAMLD1 on androgen production. MAMLD1 expression in normal steroid-producing tissues and mutant MAMLD1 protein expression were also assessed. Nine <italic>MAMLD1</italic> mutations (7 novel) were characterized. <italic>In vitro</italic>, most MAMLD1 variants acted similarly to wild type. Only the L210X mutation showed loss of function in all tests. We detected no effect of wild-type or MAMLD1 variants on CYP17A1 enzyme activity in our cell experiments, and Western blots revealed no significant differences for MAMLD1 protein expression. MAMLD1 was expressed in human adult testes and adrenals. In conclusion, our data support the notion that <italic>MAMLD1</italic> sequence variations may not suffice to explain the phenotype in carriers and that MAMLD1 may also have a role in adult life.</p>
</abstract>
<funding-group>
<funding-statement>This work was supported by grants of the Swiss National Science Foundation (320030-146127) to CEF, the Instituto de Salud Carlos III, Madrid, Spain CIBERER U-712 to MFC, the University and Research Management and Evaluation Agency, Barcelona, Spain (2009SGR31) to LA, and the private Foundation Bangerter-Rhyner, Basel, Switzerland to NC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="3"></table-count>
<page-count count="20"></page-count>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files. Each patient’s pediatric endocrinologist provided the clinical and biochemical data. The genetic analyses were performed at the Vall d’Hebron Research Institute in Barcelona and the in vitro and in silico functional studies were done at the Pediatric Endocrinology Research laboratory in Bern. The molecular studies were approved by the ethic committees of the Vall d’Hebron Research Institute, Barcelona, Spain and the Ethic Commission of the Kanton Bern, Switzerland. Data entering the study were provided by the clinicians and the genetic lab in coded forms and are stored and accessible to the scientific community as follows: a) requests for clinical and biochemical data may be addressed to specific clinicians by contacting the corresponding author, b) genetic data are accessible through the Biobank system of Vall d’Hebron (<email>biobanc@vhir.org</email>), c) experimental data may be obtained from the corresponding author directly.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<title>Data Availability</title>
<p>All relevant data are within the paper and its Supporting Information files. Each patient’s pediatric endocrinologist provided the clinical and biochemical data. The genetic analyses were performed at the Vall d’Hebron Research Institute in Barcelona and the in vitro and in silico functional studies were done at the Pediatric Endocrinology Research laboratory in Bern. The molecular studies were approved by the ethic committees of the Vall d’Hebron Research Institute, Barcelona, Spain and the Ethic Commission of the Kanton Bern, Switzerland. Data entering the study were provided by the clinicians and the genetic lab in coded forms and are stored and accessible to the scientific community as follows: a) requests for clinical and biochemical data may be addressed to specific clinicians by contacting the corresponding author, b) genetic data are accessible through the Biobank system of Vall d’Hebron (<email>biobanc@vhir.org</email>), c) experimental data may be obtained from the corresponding author directly.</p>
</notes>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>The <italic>MAMLD1</italic> (mastermind-like domain-containing 1, previously also known as <italic>CXorf6</italic>) gene (OMIM 300120) has been first identified in a patient with myotubular myopathy and male hypogenitalism who was found to harbor a deletion on chromosome Xq28 [<xref ref-type="bibr" rid="pone.0142831.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0142831.ref002">2</xref>]. Meanwhile, 20 <italic>MAMLD1</italic> sequence variations have been described in patients who have a 46,XY disorder of sex development (DSD), mostly presenting with hypospadias [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>–<xref ref-type="bibr" rid="pone.0142831.ref009">9</xref>]. However, other forms of DSD are also reported with <italic>MAMLD1</italic> gene mutations. Some patients present with cryptorchidism [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0142831.ref004">4</xref>, <xref ref-type="bibr" rid="pone.0142831.ref006">6</xref>] and/or microphallus [<xref ref-type="bibr" rid="pone.0142831.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>]. Recently, the <italic>MAMLD1</italic> gene variation P677L was found in a 46,XY patient with complete gonadal dysgenesis [<xref ref-type="bibr" rid="pone.0142831.ref010">10</xref>]. In addition, two 46,XY DSD brothers with the <italic>MAMLD1</italic> mutation Q580R presented with female external genitalia. But strikingly, their nephew with the same severe 46,XY DSD phenotype did not carry the mutation [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>]. By contrast, only one homozygous <italic>MAMLD1</italic> mutation (V505A) has been reported in a 46,XX DSD subject with gonadal dysgenesis [<xref ref-type="bibr" rid="pone.0142831.ref011">11</xref>]. She presented with primary amenorrhea, eunuchoidism, clitoromegaly and bilateral streak gonads [<xref ref-type="bibr" rid="pone.0142831.ref011">11</xref>].</p>
<p>Presently, there is some controversy about the causative role of <italic>MAMLD1</italic> gene variations and the associated DSD phenotype in carriers for the following reasons. First, some <italic>MAMLD1</italic> variants have also been detected in normal individuals (P359S, V505A, N662S) [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0142831.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0142831.ref012">12</xref>] and others are not present in all affected DSD individuals of the same family (P359S, Q580R) [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>]. Second, the male <italic>Mamld1</italic> knockout mouse has a normal genital phenotype and has normal reproduction [<xref ref-type="bibr" rid="pone.0142831.ref013">13</xref>]. Third, functional studies <italic>in vitro</italic> show normal results for several <italic>MAMLD1</italic> mutations compared to wild type (WT) when studying their effect as suggested regulators of genes involved in sex development [<xref ref-type="bibr" rid="pone.0142831.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>]. Finally, <italic>MAMLD1</italic> variants are also found in other species such as dogs, cats and horses with or without DSD [<xref ref-type="bibr" rid="pone.0142831.ref015">15</xref>–<xref ref-type="bibr" rid="pone.0142831.ref017">17</xref>].</p>
<p>Moreover, the V505A MAMLD1 variant has been found in the WT genome of the homo Neanderthal and chimpanzee [<xref ref-type="bibr" rid="pone.0142831.ref018">18</xref>]. This variant is regarded as an ancestral, potentially compensated mutation which is only disease-causing in humans [<xref ref-type="bibr" rid="pone.0142831.ref018">18</xref>]. Nevertheless, analyses of large case-control studies revealed the double S-S haplotype including MAMLD1 P359S and N662S as a risk factor for hypospadias [<xref ref-type="bibr" rid="pone.0142831.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>].</p>
<p>Little is known about the exact role of MAMLD1 in sexual development. A role in sex differentiation through supporting testosterone production in critical periods of male development has been suggested [<xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>]. Studies in mice revealed increasing <italic>Mamld1</italic> expression from E12.5 to E14.5 in fetal Leydig and Sertoli cells [<xref ref-type="bibr" rid="pone.0142831.ref013">13</xref>]. <italic>MAMLD1</italic> is controlled by SF-1 which is a key transcription factor for numerous genes involved in sex development and steroidogenesis [<xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>]. MAMLD1 transactivates also the non-canonical Notch targeted <italic>Hes3</italic> promoter [<xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>]. <italic>Hes3</italic> regulates cell differentiation and proliferation during embryonic development [<xref ref-type="bibr" rid="pone.0142831.ref019">19</xref>]. MAMLD1 seems related to the production of testosterone as its knock-down reduces testosterone production and gene expression of <italic>CYP17A1</italic> [<xref ref-type="bibr" rid="pone.0142831.ref020">20</xref>]. Studies in <italic>Mamld1</italic>-KO mice showed significantly reduced testicular expression of Leydig-specific genes such as <italic>Star</italic>, <italic>Cyp11a1</italic>, <italic>Cyp17a1</italic>, <italic>Hsd3b1</italic> and <italic>Insl3</italic>, but normal expression of other genes related to steroidogenesis and sex-development [<xref ref-type="bibr" rid="pone.0142831.ref013">13</xref>]. However, <italic>Mamld1</italic>-KO mice have normal external genitalia and are able to reproduce similar to WT animals [<xref ref-type="bibr" rid="pone.0142831.ref013">13</xref>]. Taken together, there is justified doubt whether <italic>MAMLD1</italic> gene variations are sufficient to explain the DSD phenotype in carriers warranting further studies.</p>
<p>In this study we searched for <italic>MAMLD1</italic> sequence variations in a cohort of 108 46,XY DSD individuals in whom mutations in other candidate genes (<italic>AR</italic>, <italic>SRD5A2</italic>, <italic>NR5A1</italic>) were previously ruled out. We found 9 <italic>MAMLD1</italic> mutations (7 of them novel) in 108 46,XY DSD patients (8.3%). Patients’ characteristics were compared to reported cases. <italic>In vitro</italic> functional studies revealed negative results for most <italic>MAMLD1</italic> variants. Comparative alignments showed that the original amino acids are mostly not conserved through evolution, yet V505 exists only in human. Overall, our data support the notion that <italic>MAMLD1</italic> sequence variations may not suffice to explain the DSD phenotype in carriers.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec003">
<title>Patients and genetic analyses</title>
<p>A cohort of 108 46,XY DSD individuals in whom mutations in other candidate genes (<italic>AR</italic>, <italic>SRD5A2</italic>, <italic>NR5A1</italic>) were previously ruled out was analyzed for <italic>MAMLD1</italic> sequence variation. Written informed consent was obtained from all individuals participants/legal guardians included in the study after full explanation of the purpose and nature of all the procedures used. Each patient’s pediatric endocrinologist provided the clinical and biochemical data. The genetic analyses were performed at the Vall d’Hebron Research Institute in Barcelona and the <italic>in vitro</italic> and <italic>in silico</italic> functional studies were done at the Pediatric Endocrinology Research laboratory in Bern. The molecular studies were approved by the ethic committees of the Vall d’Hebron Research Institute, Barcelona, Spain and the Ethic Commission of the Kanton Bern, Switzerland. Data entering the study were provided by the clinicians and the genetic lab in coded forms and are stored and accessible to the scientific community as follows: a) requests for clinical and biochemical data may be addressed to specific clinicians by contacting the corresponding author, b) genetic data are accessible through the Biobank system of Vall d’Hebron (<email>biobanc@vhir.org</email>), c) relevant experimental data are provided as a Supporting file (<xref ref-type="supplementary-material" rid="pone.0142831.s004">S1 File</xref>). The methods were carried out in accordance with the approved guidelines. Genomic DNA was isolated from peripheral blood leukocytes. <italic>MAMLD1</italic> coding regions, their flanking intronic sequences and part of the 5’UTR were amplified by PCR using specific primers [<xref ref-type="supplementary-material" rid="pone.0142831.s005">S1 Table</xref>, [<xref ref-type="bibr" rid="pone.0142831.ref004">4</xref>]]. The PCR products were sequenced using the BigDye Terminator v3.1 Cycle Sequencing Kit on an automated ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). Obtained sequences were analyzed against GenBank entries NG_017093.2 (genomic DNA), NM_005491.4 (mRNA) and NP_005482.2 (protein) (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/">http://www.ncbi.nlm.nih.gov/</ext-link>). Genetic analyses of the <italic>AR</italic>, <italic>SRD5A2</italic> and <italic>NR5A1</italic> genes were performed as described [<xref ref-type="bibr" rid="pone.0142831.ref021">21</xref>–<xref ref-type="bibr" rid="pone.0142831.ref023">23</xref>]. All patients were checked for these 3 genes except patient 5, which was analyzed for <italic>NR5A1</italic> only.</p>
<p>A <italic>MAMLD1</italic> SNP genotyping (rs62641609: H347Q; rs41313406: P359S; rs61740566: V505A and rs2073043: N662S) of 155 normal adult male controls was performed by TaqMan assays for allelic discrimination using the Applied Biosystem Prism 7900 HT instrument and the allelic discrimination end-point analysis mode of the Sequence Detection software package, Version 2.3 (SDS 2.3). The following custom TaqMan SNP genotyping assays were used according to the protocols supplied by Applied Biosystems: C__64647092_10; C__26000187_10; C__25995288_20; C__15950293_10. Differences between controls and patients for SNP genotype and allele frequencies were analyzed with a contingency table analysis using the JMP<sup>®</sup>7 program (SAS Institute, Inc., Cary, NC, USA).</p>
</sec>
<sec id="sec004">
<title>Tissue expression studies</title>
<p>MAMLD1 expression was studied for normal human adrenal and testicular tissues using cDNA samples purchased from amsbio (AMS Biotechnology (Europe) Limited, Abingdon, UK). According to amsbio information, cDNAs originate from two adult subjects aged 50 years for adrenals and aged 23 years for testes. Fetal material was from two samples 20 weeks gestation for adrenals and 30 weeks gestation for testes. Semiquantitative PCRs (35 cycles) for MAMLD1 expression were carried out using the recommended concentrations of the purchased cDNAs. Primers are listed in <xref ref-type="supplementary-material" rid="pone.0142831.s005">S1 Table</xref>. Agarose-gel electrophoresis was performed for the PCR products, which were detected by ethidium bromide on a UV transilluminator (Alphaimager, Proteinsimple, Santa Clara, CA, USA).</p>
</sec>
<sec id="sec005">
<title>
<italic>In vitro</italic> functional and expression studies</title>
<sec id="sec006">
<title>Cell lines</title>
<p>Steroidogenic cell lines mouse Leydig MA-10 (ATCC CRL-305; <ext-link ext-link-type="uri" xlink:href="http://www.lgcstandards-atcc.org">http://www.lgcstandards-atcc.org</ext-link>), human adrenal NCI-H295R (ATCC CRL-2128; <ext-link ext-link-type="uri" xlink:href="http://www.lgcstandards-atcc.org">http://www.lgcstandards-atcc.org</ext-link>) and the non-steroidogenic, human embryonic kidney HEK293 cell line (ATCC CRL-1573; <ext-link ext-link-type="uri" xlink:href="http://www.lgcstandards-atcc.org">http://www.lgcstandards-atcc.org</ext-link>) were used for this study. HEK293 cells were cultured in DMEM, supplemented with 10% fetal calf serum, 1% penicillin/streptomycin (Gibco, Paisley, UK) and 1% sodium pyruvate (Gibco). NCI-H295R cells were cultured in DMEM/Ham’s F12 (1:1) (Gibco), supplemented with 5% Nu serum (Becton Dickinson AG, Allschwil, Switzerland), 1% penicillin/streptomycin and 0.1% ITS Premix (Becton Dickinson). MA-10 cells were cultured in Waymouth MB 751/1 (Sigma-Aldrich Corp., St. Louis, MO, USA) supplemented with 15% Horse Serum (Gibco) and 1% penicillin/streptomycin (Gibco).</p>
</sec>
<sec id="sec007">
<title>Expression vectors</title>
<p>The promoter luciferase reporter vector Hes3_luc (-2715~+261) was kindly gifted by Dr. Maki Fukami (National Research Institute for Child Health and Development, Tokyo, Japan) [<xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>, <xref ref-type="bibr" rid="pone.0142831.ref024">24</xref>]. The human -3.7CYP17A1_Δluc vector was available from previous work [<xref ref-type="bibr" rid="pone.0142831.ref025">25</xref>, <xref ref-type="bibr" rid="pone.0142831.ref026">26</xref>]. For the MAMLD1 expression vectors, we used the WT cMyc-MAMDL1_pCMV and the minor transcript variant lacking exon 5 ΔE5 (previous ΔE4), both kindly gifted by Dr. Maki Fukami. In addition, we modified the WT cMyc-MAMLD1_pCMV vector according to the revised coding sequence NM_005491.4 (GenBank MAMLD1, isoform 2, new transcription start site in r.64, exon 2). This new WT construct was custom made by GenScript (Piscataway, NJ, USA). Mutant MAMLD1 expression vectors (c.605C&gt;T, c.626delT, c.631G&gt;A, c.1041C&gt;A, c.1075C&gt;T, c.1508C&gt;A, c.1514T&gt;C, c.1985A&gt;G, c.2170C&gt;G and c.2190G&gt;A) were generated by PCR-based site-directed mutagenesis using specific primers (<xref ref-type="supplementary-material" rid="pone.0142831.s005">S1 Table</xref>) and the QuickChange protocol by Stratagene (Agilent Technologies Inc., Santa Clara, CA, USA) using the new WT expression vector as template. The MAMLD1 mutant c.1503_1504dupCAGCAG was also custom made by GenScript. All new constructs were verified by direct sequencing.</p>
</sec>
<sec id="sec008">
<title>MAMLD1 promoter transactivation experiments</title>
<p>Cells were cultured on 24-well plates and transiently transfected (Lipofectamine 2000TM, Invitrogen) with WT or mutant MAMLD1 together with the promoter luciferase reporter constructs Hes3_luc or -3.7CYP17A1_Δluc for 6 hours. The transfection mixture contained 1.25 μg of plasmid DNA and 50 ng <italic>Renilla</italic> of luciferase reporter (pRL-TK) control per well. Forty-eight hours after transfection, cells were washed with PBS, lysed and assayed for luciferase activity with the Dual-Luciferase Reporter (DLR<sup>™</sup>) Assay System (Promega AG, Wallisellen, Switzerland) on a Veritasmicroplate Luminometer reader (Turner BioSystems Luminometer and Software by Promega). <italic>Firefly</italic> luciferase readings were standardized against <italic>Renilla</italic> control readings and results expressed as relative luciferase units (RLU). Experiments were performed in duplicates and repeated 3 times. Data are given as mean±SEM. Statistical significance was examined using Student’s t-test (Microsoft Excel). P-value for significance was set at ≤0.05.</p>
</sec>
<sec id="sec009">
<title>CYP17A1 enzyme conversion experiments</title>
<p>To measure a possible effect of MAMLD1 on CYP17A1 activity, we assessed the conversion of progesterone to 17-hydroxyprogesterone and androstenedione in steroidogenic NCI-H295R and MA-10, and non-steroidogenic HEK293 cells. For this, all cells were transfected with WT or mutant MAMLD1 and non-steroidogenic HEK293 cells in addition with human CYP17A1 in pcDNA3. Experiments were performed on 12-well plates; transient transfection was for 6 hours (1.25 μg plasmid DNA/well) and experiments were closed after 48 hours. Steroid conversion was labeled by adding 20,000 cpm<sup>14</sup>C-progesterone per well for 60 min before extracting all steroids from the cell medium. Steroids were then separated by thin layer chromatography (TLC; Macherey-Nagel, Düren, Germany) using the chloroform:ethylacetate (3:1) solvent system and steroid standards. TLC plates were exposed on imaging screens to visualize the radioactive steroids. The screens were read on a Fuji PhosphoImager Fla-7000 (Fujifilm, Dielsdorf, Germany). Steroids were identified according to known stardards and densitometrically quantified as % of total radioactivity per sample using Multi Gauge software (Fujifilm). Experiments were performed 2 times in 3 different cell line backgrounds.</p>
</sec>
<sec id="sec010">
<title>MAMLD1 protein expression studies</title>
<p>Leydig MA-10 cells were transiently transfected with either WT (WT, original WT of ΔE5) or mutant MAMLD1 expression vectors, which all carried a Myc-tag. Cells were lysed and a Western blot was performed using an antibody against c-Myc (C6594, Sigma, Saint Louis, USA). Experiments were repeated twice. Expression of β-actin was the control.</p>
</sec>
</sec>
<sec id="sec011">
<title>
<italic>In silico</italic> analysis</title>
<p>The following databases and computational tools were used. CLC Sequence Viewer software (2014 CLC bio, QIAGEN) was used to search for homologies of MAMLD1 through species. Polymorphism Phenotyping v2 (PolyPhen-2, <ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/index.shtml">http://genetics.bwh.harvard.edu/pph2/index.shtml</ext-link>) [<xref ref-type="bibr" rid="pone.0142831.ref027">27</xref>] was used to predict the possible impact of amino acid substitutions on the structure and function of MAMLD1. We searched for functional partners of MAMLD1 with the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING, <ext-link ext-link-type="uri" xlink:href="http://string-db.org/">http://string-db.org/</ext-link>), developed at the Center for Protein Research (CPR), EMBL, Swiss Institute of Bioinformatics (SIB), University of Copenhagen (KU), Technical University of Dresden (TUD) and University of Zurich (UZH). The Biological General Repository for Interaction Datasets (BioGRID, <ext-link ext-link-type="uri" xlink:href="http://thebiogrid.org">thebiogrid.org</ext-link>), developed at Princeton University, University of Montreal, University of Edinburgh and Mount Sinai Hospital, is a public database that was searched for protein interactions.</p>
</sec>
</sec>
<sec id="sec012" sec-type="results">
<title>Results</title>
<sec id="sec013">
<title>Patients’ genotypes and phenotypes</title>
<p>We searched for mutations in the MAMLD1 gene (<xref ref-type="fig" rid="pone.0142831.g001">Fig 1A</xref>) in a cohort of 108 46,XY DSD patients from Spain and Switzerland. <italic>MAMLD1</italic> is located on Xq28. The original <italic>MAMLD1</italic> gene sequence has been recently revised [<xref ref-type="bibr" rid="pone.0142831.ref006">6</xref>] for a new upstream transcriptional start site (TSS): +64 (exon 2) (old TSS +284) which has caused a renumbering of exons and sequence (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/gene/10046">http://www.ncbi.nlm.nih.gov/gene/10046</ext-link>) and a renaming of the previously identified mutations (<xref ref-type="fig" rid="pone.0142831.g001">Fig 1</xref>). MAMLD1 presents with 3 different isoforms (<xref ref-type="fig" rid="pone.0142831.g001">Fig 1A</xref>). Isoform 2 (NM_005491.4, NP_005482, ENST00000262858, 774 amino acids), which is coded by exons 2 to 7, is considered the canonical sequence and has been studied previously [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0142831.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0142831.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0142831.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>]. Isoform 3 (NM_001177466, NP_001170937, ENST00000426613, 749 amino acids) is identical to isoform 2, but lacks exon 3. Isoform 1 (NM_001177465, NP_001170936, ENST00000432680, 998 amino acids) has a non-coding upstream codon, lacks exon 3, and has a different C-terminus compared to isoforms 2 and 3 due to a translational frameshift after exon 4.</p>
<fig id="pone.0142831.g001" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0142831.g001</object-id>
<label>Fig 1</label>
<caption>
<title>MAMLD1 transcripts, reported mutations and tissue expression.</title>
<p>A. Schemes of the 3 MAMLD1 human transcripts are shown (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/">http://www.ncbi.nlm.nih.gov/</ext-link>; <ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org">http://www.ensembl.org</ext-link>). B. Scheme showing all reported <italic>MAMLD1</italic> gene mutations. Mutations described in this study are shown in red and the novel ones are marked with an asterisk. C. Assessment of MAMLD1 expression in human fetal and adult adrenal and testis. Semiquantitative RT-PCRs were performed using specific primers (<xref ref-type="supplementary-material" rid="pone.0142831.s005">S1 Table</xref>). GAPDH was used as the internal control. A representative gel picture is shown (n = 3). For MAMLD1 the band at 581 bp corresponds to isoform 2 and the band at 506 bp to isoforms 1 and 3. Dashed red lines in A indicate the location of the PCR fragments amplified for the expression studies.</p>
</caption>
<graphic xlink:href="pone.0142831.g001"></graphic>
</fig>
<p>In our cohort of 46,XY DSD a total of 9 sequence variations were detected (<xref ref-type="fig" rid="pone.0142831.g001">Fig 1B</xref>). Three <italic>MAMLD1</italic> sequence variations were considered SNPs, but had been previously described in both controls and 46,XY DSD individuals (rs41313406: c.1075C&gt;T, P359S; rs61740566: c.1514T&gt;C, V505A and rs2073043: c.1985A&gt;G, N662S) [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>–<xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>]; one was previously detected in 46,XY patients only (rs62641609: c.1041C&gt;A, H347Q) [<xref ref-type="bibr" rid="pone.0142831.ref006">6</xref>], and 7 were novel (c.605C&gt;T, p.T202M; c.626delT; p.L210X; c.631G&gt;A, p.D211N; c.1503_1504dupCAGCAG, p.Q501Q502; c.1508C&gt;A, p.A503E; c.2170C&gt;G, p.L724V and c.2190G&gt;A, p.S730S). Nine sequence variations found in 9 patients were considered potentially pathogenic. These patients manifested with a broad range of 46,XY DSD phenotype (<xref ref-type="table" rid="pone.0142831.t001">Table 1</xref>). Six patients presented rather severe hypospadias, 2 also had cryptorchidism, and 1 presented with normal external female genitalia with gonads palpable in the genital folds. Four 46,XY subjects were reared as females, 5 as males. Testis histology was studied in 3 patients between age 2 weeks and 2 years and was normal. Hormonal studies for gonadal function demonstrated normal baseline and/or hCG stimulated testosterone production and normal AMH levels (<xref ref-type="table" rid="pone.0142831.t001">Table 1</xref>). Subject 5 claimed to have fathered a child. Adrenal function tests were normal in all tested patients. Additional diagnoses were present in 3 patients, 1 related to a 22q11 deletion syndrome (subject 8, <xref ref-type="table" rid="pone.0142831.t001">Table 1</xref>).</p>
<table-wrap id="pone.0142831.t001" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0142831.t001</object-id>
<label>Table 1</label>
<caption>
<title>Clinical, biochemical and genetic characteristics of the patients harboring mutations and polymorphisms in the <italic>MAMLD1</italic> gene.</title>
</caption>
<alternatives>
<graphic id="pone.0142831.t001g" xlink:href="pone.0142831.t001"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" colspan="1" rowspan="1">Patient</th>
<th align="center" colspan="1" rowspan="1">Origin, YOB</th>
<th align="center" colspan="1" rowspan="1">Karyotype, Assigned sex</th>
<th align="center" colspan="1" rowspan="1">
<italic>MAMLD1</italic> gene mutation</th>
<th align="center" colspan="1" rowspan="1">Genital anatomy</th>
<th align="center" colspan="1" rowspan="1">Testes histology (age)</th>
<th align="center" colspan="1" rowspan="1">Gonadal function (age)</th>
<th align="center" colspan="1" rowspan="1">Adrenal function (age)</th>
<th align="center" colspan="1" rowspan="1">Remarks</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1">1</td>
<td align="center" colspan="1" rowspan="1">Spain, 2009</td>
<td align="center" colspan="1" rowspan="1">46,XY, Male</td>
<td align="center" colspan="1" rowspan="1">
<bold>T202M</bold>, c.605C&gt;T</td>
<td align="center" colspan="1" rowspan="1">Penoscrotal hypospadias. Small penis. Unilateral cryptorchidia.</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">Normal T (minipuberty). Normal gonadotropins. No hCG test.</td>
<td align="center" colspan="1" rowspan="1">ND</td>
<td align="center" colspan="1" rowspan="1">SGA. Short stature. Low implantation thumbs.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">2</td>
<td align="center" colspan="1" rowspan="1">Spain, 1999</td>
<td align="center" colspan="1" rowspan="1">46,XY, Female</td>
<td align="center" colspan="1" rowspan="1">
<bold>L210X</bold>, c.626delT and <bold>D211N</bold>, c.631G&gt;A</td>
<td align="center" colspan="1" rowspan="1">Penoscrotal hypospadias. Small penis. Testes 0.5 ml.</td>
<td align="center" colspan="1" rowspan="1">Normal for age (15 d).</td>
<td align="center" colspan="1" rowspan="1">Normal T (baseline) and hCG test (10 days).</td>
<td align="center" colspan="1" rowspan="1">Normal baseline (15 d).</td>
<td align="center" colspan="1" rowspan="1">Abnormal GGN repeat in <italic>AR</italic>. Mother non-carrier; norfloxacine treatment during pregnancy.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">3</td>
<td align="center" colspan="1" rowspan="1">Spain, 2005</td>
<td align="center" colspan="1" rowspan="1">46,XY, Female</td>
<td align="center" colspan="1" rowspan="1">
<bold>H347Q</bold>, c.1041C&gt;A, <italic>rs62641609</italic>
</td>
<td align="center" colspan="1" rowspan="1">Female genitalia. Gonads in labia.</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">Normal hCG test (2 y).</td>
<td align="center" colspan="1" rowspan="1">Normal baseline (2 y).</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">4</td>
<td align="center" colspan="1" rowspan="1">Spain, 2008</td>
<td align="center" colspan="1" rowspan="1">46,XY, Male</td>
<td align="center" colspan="1" rowspan="1">
<bold>H347Q</bold>, c.1041C&gt;A, <italic>rs62641609</italic>
</td>
<td align="center" colspan="1" rowspan="1">Penoscrotal hypospadias. Testes 2 ml.</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">Normal hCG test. Normal AMH (2.5 y).</td>
<td align="center" colspan="1" rowspan="1">Normal baseline (2.5 y).</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">5</td>
<td align="center" colspan="1" rowspan="1">Switzerland, 1942</td>
<td align="center" colspan="1" rowspan="1">46,XY, Male</td>
<td align="center" colspan="1" rowspan="1">
<bold>Q501Q502</bold>, c.1503_1504dupCAGCAG</td>
<td align="center" colspan="1" rowspan="1">Hypospadias. Short penis. Delayed puberty. Testes 8 ml.</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">Baseline T and gonadotropins normal (70 y). Fathered a boy.</td>
<td align="center" colspan="1" rowspan="1">Normal baseline (70 y).</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">6</td>
<td align="center" colspan="1" rowspan="1">Spain, 2001</td>
<td align="center" colspan="1" rowspan="1">46,XY, Male</td>
<td align="center" colspan="1" rowspan="1">
<bold>A503E</bold>, c.1508C&gt;A</td>
<td align="center" colspan="1" rowspan="1">Penoscrotal hypospadias. Small penis. Testes 2 ml.</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">Normal baseline T (3 m). Normal hCG test (9 m).</td>
<td align="center" colspan="1" rowspan="1">Normal baseline (3 d).</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">7</td>
<td align="center" colspan="1" rowspan="1">Spain (Venezuelan origin), 2000</td>
<td align="center" colspan="1" rowspan="1">46,XY, Female</td>
<td align="center" colspan="1" rowspan="1">
<bold>V505A</bold>, c.1514T&gt;C, <italic>rs61740566</italic>
</td>
<td align="center" colspan="1" rowspan="1">Penoscrotal hypospadias. Small penis. Unilateral cryptorchidia.</td>
<td align="center" colspan="1" rowspan="1">Normal for age (2 y).</td>
<td align="center" colspan="1" rowspan="1">Normal hCG test.</td>
<td align="center" colspan="1" rowspan="1">Normal Synacthen test.</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">8</td>
<td align="center" colspan="1" rowspan="1">Spain (North African origin), 2010</td>
<td align="center" colspan="1" rowspan="1">46,XY, Male</td>
<td align="center" colspan="1" rowspan="1">
<bold>L724V</bold>, c.2170C&gt;G</td>
<td align="center" colspan="1" rowspan="1">Penoscrotal hypospadias. Small penis. Testes 1 ml.</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">Normal prepubertal baseline T (15 m). Normal AMH.</td>
<td align="center" colspan="1" rowspan="1">Normal baseline (15 m).</td>
<td align="center" colspan="1" rowspan="1">Esophageal atresia. Right aortic arch.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">9</td>
<td align="center" colspan="1" rowspan="1">Spain, 1990</td>
<td align="center" colspan="1" rowspan="1">46,XY, Female</td>
<td align="center" colspan="1" rowspan="1">
<bold>S730S</bold>, c.2190G&gt;A</td>
<td align="center" colspan="1" rowspan="1">Penoscrotal hypospadias. Small penis.</td>
<td align="center" colspan="1" rowspan="1">Normal for age (nests of Normal Leydig cells; normal fertility index (1 y).</td>
<td align="center" colspan="1" rowspan="1">Normal baseline (12 m). No hCG test.</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">Müllerian ducts.</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001">
<p>ND: not done. d: day(s), m: month(s), y: year(s).</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec014">
<title>
<italic>MAMLD1</italic> polymorphism testing</title>
<p>We chose 4 <italic>MAMLD1</italic> variants (H347Q, P359S, V505A and N662S), previously detected in controls and 46,XY DSD patients [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0142831.ref005">5</xref>–<xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>] and/or referenced in dbSNP (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp/">http://www.ncbi.nlm.nih.gov/snp/</ext-link>) to compare their genotype and allele frequency in a cohort of 155 normal adult male controls (<xref ref-type="table" rid="pone.0142831.t002">Table 2</xref>) and our cohort of 108 46,XY patients (<xref ref-type="table" rid="pone.0142831.t002">Table 2</xref>) (with phenotypes varying from penoscrotal hypospadias to female external genitalia and including the 9 in whom <italic>MAMLD1</italic> sequence variations were detected, <xref ref-type="table" rid="pone.0142831.t001">Table 1</xref>). The MAMLD1 variants H347Q and V505A were not found in our 155 normal adult male controls suggesting a causative role for these genetic variations; the H347Q variant was not present in two exome pools of the European population (<ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/">http://evs.gs.washington.edu/EVS/</ext-link> and.<ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/about">http://exac.broadinstitute.org/about</ext-link>), but the V505A was detected in 0.05% and 0.1% of these European subjects, and in 17.8% of African people (<ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/about">http://exac.broadinstitute.org/about</ext-link>). The variants P359S and N662S were also quite frequently found in our controls (<xref ref-type="table" rid="pone.0142831.t002">Table 2</xref>), and frequencies were similar in the databases. Linkage analysis of variants P359S and N662S was positive for 84% and 92% of controls and 46,XY DSD carrying the N662S variant (<xref ref-type="table" rid="pone.0142831.t002">Table 2</xref>), thus indicating high co-segregation of both variants.</p>
<table-wrap id="pone.0142831.t002" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0142831.t002</object-id>
<label>Table 2</label>
<caption>
<title>Study of polymorphisms in the <italic>MAMLD1</italic> gene.</title>
</caption>
<alternatives>
<graphic id="pone.0142831.t002g" xlink:href="pone.0142831.t002"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1">Controls (n = 155)</th>
<th align="center" colspan="1" rowspan="1">46,XY DSD (n = 108)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1">Sequence change, <bold>NM_005491.3</bold> (NT_167198.1/ U46023)</td>
<td align="center" colspan="1" rowspan="1">Allele</td>
<td align="center" colspan="1" rowspan="1">Frequency (n)</td>
<td align="center" colspan="1" rowspan="1">Frequency (n)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">
<bold>H347Q</bold> (H274Q) <italic>rs62641609</italic>
</td>
<td align="center" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">1.00 (155)</td>
<td align="left" colspan="1" rowspan="1">0.98 (106)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">A</td>
<td align="left" colspan="1" rowspan="1">0.00 (0)</td>
<td align="left" colspan="1" rowspan="1">0.02 (2)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">
<bold>P359S</bold> (P286S) <italic>rs41313406</italic>
</td>
<td align="center" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">0.85 (134)</td>
<td align="left" colspan="1" rowspan="1">0.90 (97)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">T</td>
<td align="left" colspan="1" rowspan="1">0.15 (21)</td>
<td align="left" colspan="1" rowspan="1">0.10 (11)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">
<bold>V505A</bold> (V423A) <italic>rs61740566</italic>
</td>
<td align="center" colspan="1" rowspan="1">T</td>
<td align="left" colspan="1" rowspan="1">1.00 (155)</td>
<td align="left" colspan="1" rowspan="1">0.99 (107)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">C</td>
<td align="left" colspan="1" rowspan="1">0.00 (0)</td>
<td align="left" colspan="1" rowspan="1">0.01 (1)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">
<bold>N662S</bold> (N589S) <italic>rs2073043</italic>
</td>
<td align="center" colspan="1" rowspan="1">A</td>
<td align="left" colspan="1" rowspan="1">0.84 (130)</td>
<td align="left" colspan="1" rowspan="1">0.89 (96)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">G</td>
<td align="left" colspan="1" rowspan="1">0.16 (25)</td>
<td align="left" colspan="1" rowspan="1">0.11 (12)</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
<sec id="sec015">
<title>MAMLD1 tissue expression</title>
<p>We studied MAMLD1 expression for human fetal and adult adrenal and testis tissues. We found that MAMLD1 is expressed in the adult adrenal and testis, and the fetal testis. No expression was found in the fetal adrenal (<xref ref-type="fig" rid="pone.0142831.g001">Fig 1C</xref>). We detected all 3 isoforms in similar quantities.</p>
</sec>
<sec id="sec016">
<title>
<italic>In vitro</italic> and functional studies</title>
<p>In 2012 the reference sequence of <italic>MAMLD1</italic> has been revised (GenBank NM_005491.4, [<xref ref-type="bibr" rid="pone.0142831.ref006">6</xref>]). Therefore, we modified the human MAMLD1 expression plasmid which has been originally used for functional studies in all published studies accordingly. We then first performed promoter transactivation studies (<xref ref-type="fig" rid="pone.0142831.g002">Fig 2</xref>) with the <italic>Hes3</italic> promoter reporter in non-steroidogenic HEK293 cells to compare the activity of the revised MAMLD1 WT vector with the original WT (<xref ref-type="fig" rid="pone.0142831.g002">Fig 2A</xref>). We found similar transactivation activity on the <italic>Hes3</italic> promoter construct for both WT isoforms (revised and original) as well as for the revised shorter isoform without exon 5.</p>
<fig id="pone.0142831.g002" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0142831.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Transactivation activity of MAMLD1 on the <italic>Hes3</italic> promoter.</title>
<p>HEK293 cells were transiently transfected with wild-type (WT) and mutant MAMLD1 expression vectors and with a <italic>Hes3</italic> promoter luciferase reporter construct. Luciferase activity was measured with the Promega Dual Luciferase assay system. A. Comparison of the newly constructed MAMLD1 WT expression vector (WT (a), NM_005491.4) with the older WT (WT (b)), and ΔE5 (ΔE5 (b)) constructs [<xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>]. Similar transactivation activity on the <italic>Hes3</italic> promoter was found for all constructs. B. <italic>Hes3</italic> transactivation by WT and the 11 MAMLD1 mutants was assessed. Only the L210X MAMLD1 mutant showed an impaired activity on the <italic>Hes3</italic> promoter. Results are expressed in relative light units (RLU) and represent the mean and SEM of 3 independent experiments performed in duplicate. ΔE5: original WT (b) without exon 5 [<xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>]; * <italic>p</italic>≤0.05.</p>
</caption>
<graphic xlink:href="pone.0142831.g002"></graphic>
</fig>
<p>We then created mutant MAMLD1 expression vectors by site-directed mutagenesis according to identified sequence variations in our 46,XY DSD patients. For unclear test results in the literature [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0142831.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>], we added MAMLD1 P359S and N662S to our test series. The ability of these 11 MAMLD1 variants to transactivate the <italic>Hes3</italic> promoter in HEK293 cells was then assessed (<xref ref-type="fig" rid="pone.0142831.g002">Fig 2B</xref>). Surprisingly, only the L210X mutant lost transcriptional activity compared to WT.</p>
<p>Given these results, we performed similar studies with the human <italic>CYP17A1</italic> promoter (<xref ref-type="fig" rid="pone.0142831.g003">Fig 3</xref>), as studies in mice revealed an effect of MAMLD1 on CYP17A1 expression, activity and testosterone production [<xref ref-type="bibr" rid="pone.0142831.ref013">13</xref>, <xref ref-type="bibr" rid="pone.0142831.ref020">20</xref>]. Again, most MAMLD1 variants showed WT effect on the <italic>CYP17A1</italic> promoter reporter (<xref ref-type="fig" rid="pone.0142831.g003">Fig 3A</xref>). Similar to the <italic>Hes3</italic> promoter, mutant L210X showed a loss of activity on the <italic>CYP17A1</italic> promoter, while variants L724V and S730S showed a decrease in promoter activation compared to WT (<italic>p</italic> = 0.052 for S730S).</p>
<fig id="pone.0142831.g003" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0142831.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Effect of MAMLD1 on CYP17A1 promoter and enzyme activities.</title>
<p>HEK293 cells or NCI-H295R cells were transiently transfected with MAMLD1 WT and mutant expression vectors. For promoter activation studies, the (-3.7kb) <italic>CYP17A1</italic> promoter luciferase reporter construct was co-transfected. A. <italic>CYP17A1</italic> promoter activation by MAMLD1 was assessed by the Promega Dual luciferase assay in HEK293 cells. Only for mutant MAMLD1 L210X and L724V an impaired <italic>CYP17A1</italic> activation was found. Results are expressed in RLU and represent the mean and SEM of 3 independent experiments performed in duplicate. B. The effect of WT and mutant MAMLD1 on CYP17A1 enzyme activity was assessed in transfected NCI-H295R, MA-10 and HEK293 cells by measuring the conversion of progesterone to 17-hydroxyprogesterone. Steroid production was labeled with [<sup>14</sup>C]progesterone for 60 min. Steroids were extracted and resolved by thin-layer chromatography, then quantified as % conversion. A representative steroid profile obtained from NCI-H295R cells is shown (n = 2). No effect of MAMLD1 on CYP17A1-hydroxylase activity was detected. P: progesterone; 17OHP: 17-hydroxyprogesterone; RLU: relative light units; Ve: empty vector; WT: wild type; NT: non-transfected; * <italic>p</italic>≤0.05.</p>
</caption>
<graphic xlink:href="pone.0142831.g003"></graphic>
</fig>
<p>Next, we also tested the effect of WT and MAMLD1 variants on CYP17A1 enzymatic activity. For that we transfected MAMLD1 expression vectors into human adrenal NCI-H295R and into mouse Leydig MA-10 cells. We also co-transfected MAMLD1 expression vectors together with a CYP17A1 expression vector into non-steroidogenic HEK293 cells. After transfection, activity of CYP17A1 was assessed by measuring the conversion of radiolabeled progesterone to 17-hydroxyprogesterone (<xref ref-type="fig" rid="pone.0142831.g003">Fig 3B</xref>, <xref ref-type="supplementary-material" rid="pone.0142831.s002">S2 Fig</xref>). We found no difference for CYP17A1 activity for WT MAMLD1 and variants in all 3 cell systems (data for NCI-H295R cells in <xref ref-type="fig" rid="pone.0142831.g003">Fig 3B</xref>; data for MA-10 and HEK293 in <xref ref-type="supplementary-material" rid="pone.0142831.s002">S2 Fig</xref>). Remarkably, there was also no difference between the control vector and the WT MAMLD1 indicating that MAMLD1 does not regulate human CYP17A1 activity or that the effect is indirect through essential co-factors that were not present in the 3 cell systems used for our experiments.</p>
<p>Some <italic>MAMLD1</italic> nonsense mutants have been suggested to affect protein expression by nonsense mediated RNA decay [E197X (old E124X), Q270X (old Q197X) and R726X (old R653X) [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>]]. Therefore, we analyzed protein expression of WT and mutant MAMLD1 in MA-10 cells. Cells were transfected with the MAMLD1 expression vectors containing a Myc-tag, then Western blots were performed using an antibody against c-Myc (<xref ref-type="fig" rid="pone.0142831.g004">Fig 4</xref>). We found no significant difference for MAMLD1 protein expression for almost all of the tested variants compared to WT. The L210X mutant presented a lower band on the Western blot according to its shorter length and its amount may therefore not be compared to the full-length missense variants.</p>
<fig id="pone.0142831.g004" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0142831.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Protein expression of MAMLD1.</title>
<p>Mouse testis Leydig MA-10 cells were transiently transfected with Myc-tagged expression vectors for WT or mutant MAMLD1. Cells were lysed and Western blot (WB) was performed using anti-Myc antibody. B-actin was the control. A representative WB is shown. Two independent experiments were performed showing no significant variation in protein expression for wild-type (WT) or mutant MAMLD1. L210X gave a shorter protein. Ve: empty vector; WT: wild-type; WT(a): original WT construct; ΔE5(a): original construct lacking exon 5 [<xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>].</p>
</caption>
<graphic xlink:href="pone.0142831.g004"></graphic>
</fig>
</sec>
<sec id="sec017">
<title>
<italic>In silico</italic> analyses</title>
<p>PolyPhen-2 (<ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/index.shtml">http://genetics.bwh.harvard.edu/pph2/index.shtml</ext-link>) [<xref ref-type="bibr" rid="pone.0142831.ref027">27</xref>] was used to predict the possible impact of amino acid substitutions due to missense mutations T202M, D211N, P359S, H347Q, A503E, V505A, N662S and L724V on the structure and function of MAMLD1 (NP_005482.2). Using standard parameters [<xref ref-type="bibr" rid="pone.0142831.ref027">27</xref>], only T202M, H347Q and L724V were considered probably damaging.</p>
<p>Variants T202M, D211N, H347Q, P359S and A503E are predicted to impact on protein function because the amino acid change comprises a change in the physico-chemical property. Proline is a bending amino acid, thus it may cause a change in the conformation of the protein and it is therefore considered important. According to this, P359 could have some effect on the protein function, although it is not a conserved position in mammals (<xref ref-type="supplementary-material" rid="pone.0142831.s001">S1 Fig</xref>).</p>
<p>Furthermore, we aligned the human MAMLD1 isoform 2 (774 amino acids) with homologous sequences (ranging 720–820 amino acids) from 40 mammalian species with the CLC Sequence Viewer software (<xref ref-type="supplementary-material" rid="pone.0142831.s001">S1 Fig</xref>). To study all detected species available in the NCBI database (e.g. beyond mammals) was not possible because of high variability in length. L210 and L724 (1 change each) are conserved along mammalian evolution, followed by S730 (deleted amino acid (-) in 2 species). They might therefore be of importance for protein function. The remaining variants’ positions T202, D211, P359, Q501Q502, A503, V505 and N662 are not conserved and therefore not considered important for protein function. Variants in positions 202, 347, 505 and 662 are WT in other mammals indicating that these amino acid changes may not be of importance. T202 and S202 are similarly found: T202 is present in one third of the species (primates and bovidae), while the other mammals present S202. For position 347, H is mainly present, but 2 other changes, including our variant Q347 (in 10 species), are seen. V505 is only present in human, whereas most other mammals harbor A505 (27 species), suggesting that human V505A may just be a reversion to the ancestral state. In position N662 4 variants are present including the variant S662. Finally, the duplication Q501Q502 lies in a Q sequence, which has variable length in different species. This indicates that the length change may not harm the protein function.</p>
</sec>
</sec>
<sec id="sec018" sec-type="conclusions">
<title>Discussion</title>
<p>We detected 7 novel and 2 previously published <italic>MAMLD1</italic> sequence variations in 9 46,XY DSD patients presenting with a broad phenotype (<xref ref-type="table" rid="pone.0142831.t001">Table 1</xref>). Similar to other studies, we found that for <italic>MAMLD1</italic> sequence variations genotype-phenotype correlation and functional studies reveal ambiguous results. In our series only the truncated <italic>MAMLD1</italic> L210X mutation, found in a severely affected 46,XY DSD patient, showed loss of function in transactivation assays using the <italic>Hes3</italic> and the <italic>CYP17A1</italic> promoters as interacting partner. L201X can therefore be considered a deleterious mutation. Remarkably, this patient also presented with hypogonadotropic hypogonadism at pubertal age suggesting that MAMLD1 may also be involved in the HPG axis, what has not been described so far, or that the patient may harbor additional genetic defects. By contrast, L724V, carried by a 46,XY DSD patient with a typical MAMLD1 phenotype (46,XY male with penoscrotal hypospadias and small penis), and the synonymous S730 mutation, found in 46,XY female patient (also with penoscrotal hypospadias and small penis), had only impaired <italic>CYP17A1</italic> but normal <italic>Hes3</italic> transactivation activity. Both positions are conserved in mammals. Although variant H347Q showed no functional impairment in our in vitro tests, its presence in 2 of our patients with a severe 46,XY DSD phenotype (female and ambiguous genitalia) and in a published 46,XY DSD patient with hypospadias and microphallus [<xref ref-type="bibr" rid="pone.0142831.ref006">6</xref>], as well as its absence in 155 control males suggests a disease causing role. Variant V505A, which we found in one patient, has been previously described in 2 46,XY DSD subjects [<xref ref-type="bibr" rid="pone.0142831.ref004">4</xref>, <xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>] and in a 46,XX dysgenetic woman [<xref ref-type="bibr" rid="pone.0142831.ref011">11</xref>]. Interestingly, this human variant is the WT found in the genome of the Neanderthal, the chimpanzee and many other species and has been discussed to be an ancestral, potentially compensated mutation [<xref ref-type="bibr" rid="pone.0142831.ref018">18</xref>].</p>
<p>According to published literature of microdeletions and rearrangements in the Xq28 region containing the MAMLD1-MTM1-MTMR1 genes [see <xref ref-type="table" rid="pone.0142831.t003">Table 3</xref> and [<xref ref-type="bibr" rid="pone.0142831.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0142831.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0142831.ref028">28</xref>–<xref ref-type="bibr" rid="pone.0142831.ref030">30</xref>]], which causes myopathy for the involvement of the MTM1 gene, it appears for the DSD phenotype that the C-terminal region of the MAMLD1 gene is critical for abnormal sex development [<xref ref-type="bibr" rid="pone.0142831.ref029">29</xref>]. By contrast, MAMLD1 variants which have been associated with DSD are found throughout the gene (<xref ref-type="fig" rid="pone.0142831.g001">Fig 1B</xref>).</p>
<table-wrap id="pone.0142831.t003" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0142831.t003</object-id>
<label>Table 3</label>
<caption>
<title>Summary of reported patients harboring sequence variations and deletions affecting <italic>MAMLD1</italic> gene <xref ref-type="table-fn" rid="t003fn001">
<sup>a</sup>
</xref>.</title>
</caption>
<alternatives>
<graphic id="pone.0142831.t003g" xlink:href="pone.0142831.t003"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" colspan="1" rowspan="1">Mutation number, Reference</th>
<th align="center" colspan="1" rowspan="1">Karyotype, Assigned sex</th>
<th align="center" colspan="1" rowspan="1">
<italic>MAMLD1</italic> gene mutation</th>
<th align="center" colspan="1" rowspan="1">Genital anatomy</th>
<th align="center" colspan="1" rowspan="1">Gonadal function, Gonadal histology</th>
<th align="center" colspan="1" rowspan="1">Adrenal function</th>
<th align="center" colspan="1" rowspan="1">Family, Other data</th>
<th align="center" colspan="1" rowspan="1">Present in controls?</th>
<th align="center" colspan="1" rowspan="1">Functional/additional studies</th>
<th align="center" colspan="1" rowspan="1">Additional phenotype Other genetic studies</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>1</bold>. Metwalley and Farghaly, 2012 [<xref ref-type="bibr" rid="pone.0142831.ref008">8</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 1 male</td>
<td align="left" colspan="1" rowspan="1">c.325delG</td>
<td align="left" colspan="1" rowspan="1">Distal hypospadias with chordee and normal testes</td>
<td align="left" colspan="1" rowspan="1">Profile consistant with X-linked congenital adrenal hypoplasia</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Egyptian origin</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">
<italic>Mutation in DAX-1</italic> (R327P)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>2</bold>. Kalfa <italic>et al</italic>., 2012 [<xref ref-type="bibr" rid="pone.0142831.ref006">6</xref>]</td>
<td align="left" colspan="1" rowspan="1">46,XY, 1 male</td>
<td align="left" colspan="1" rowspan="1">c.428C&gt;A, S143X</td>
<td align="left" colspan="1" rowspan="1">Scrotal hypospadias, microphallus, intrascrotaltestis</td>
<td align="left" colspan="1" rowspan="1">Normal T, LH, FSH, AMH, Inhibin</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Mother heteterozygous, uncle severe hypospadias, maternal cousin severe hypospadias (not available for testing)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Loss of transactivation activity on Hes3</td>
<td align="left" colspan="1" rowspan="1">N: <italic>AR</italic>, <italic>SRD5A2</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>3</bold>. Kalfa <italic>et al</italic>., 2008 [<xref ref-type="bibr" rid="pone.0142831.ref004">4</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 1 male</td>
<td align="left" colspan="1" rowspan="1">c.546del, E182fsX121</td>
<td align="left" colspan="1" rowspan="1">Proximal hypospadias, inguinal testis</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Normal</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>3</bold>. Kalfa <italic>et al</italic>., 2008 [<xref ref-type="bibr" rid="pone.0142831.ref004">4</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 1 male</td>
<td align="left" colspan="1" rowspan="1">c.546del, E182fsX121</td>
<td align="left" colspan="1" rowspan="1">Penoscrotal hypospadias with chordee, intrascrotal testis</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Normal</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>4</bold>. Fukami <italic>et al</italic>., 2006 [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>]; Fukami <italic>et al</italic>., 2008 [<xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 2 males, half brothers</td>
<td align="left" colspan="1" rowspan="1">c.589G&gt;T, E197X rs121909493</td>
<td align="left" colspan="1" rowspan="1">1<sup>st</sup>: penoscrotal hypospadias, inguinal testes; 2<sup>nd</sup>: penoscrotal hypospadias, scrotal testes; penis 2.5 cm</td>
<td align="left" colspan="1" rowspan="1">All normal, FSH low</td>
<td align="left" colspan="1" rowspan="1">Normal</td>
<td align="left" colspan="1" rowspan="1">Japanese origin. Mother heterozygous</td>
<td align="left" colspan="1" rowspan="1">Absent in 150 Japanese males</td>
<td align="left" colspan="1" rowspan="1">Causes non-mediated RNA decay. Reduced leukocyte transcripts. No transactivation activity on Hes3, reduced protein expression</td>
<td align="left" colspan="1" rowspan="1">N: <italic>AR</italic>, <italic>SRD5A2</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>5</bold>. Fukami <italic>et al</italic>., 2006 [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>]; Fukami <italic>et al</italic>., 2008 [<xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 1 male</td>
<td align="left" colspan="1" rowspan="1">c.808C&gt;T, Q270X rs121909494</td>
<td align="left" colspan="1" rowspan="1">Penoscrotal hypospadias, scrotal testes; penis 2 cm</td>
<td align="left" colspan="1" rowspan="1">Normal</td>
<td align="left" colspan="1" rowspan="1">Normal</td>
<td align="left" colspan="1" rowspan="1">Japanese origin. Mother not studied</td>
<td align="left" colspan="1" rowspan="1">Absent in 150 Japanese males</td>
<td align="left" colspan="1" rowspan="1">Causes non-mediated RNA decay. Reduced leukocyte transcripts. No transactivation activity on Hes3, increased protein expression</td>
<td align="left" colspan="1" rowspan="1">N: <italic>AR</italic>, <italic>SRD5A2</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>6</bold>. Kalfa <italic>et al</italic>., 2012 [<xref ref-type="bibr" rid="pone.0142831.ref006">6</xref>]</td>
<td align="left" colspan="1" rowspan="1">46,XY (1/70), 1 male</td>
<td align="left" colspan="1" rowspan="1">c.1041C&gt;A, H347Q, rs62641609</td>
<td align="left" colspan="1" rowspan="1">Posterior hypospadias, microphallus</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>7</bold>. Kalfa <italic>et al</italic>., 2012 [<xref ref-type="bibr" rid="pone.0142831.ref006">6</xref>]</td>
<td align="left" colspan="1" rowspan="1">46,XY, 5 males</td>
<td align="left" colspan="1" rowspan="1">c.1075C&gt;T, P359S, rs41313406</td>
<td align="left" colspan="1" rowspan="1">Non-syndromic DSD</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>7</bold>. Fukami <italic>et al</italic>., 2006 [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>]; Fukami <italic>et al</italic>., 2008 [<xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 1 male</td>
<td align="left" colspan="1" rowspan="1">c.1075C&gt;T, P359S, rs41313406</td>
<td align="left" colspan="1" rowspan="1">Hypospadias</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Swedish origin. Absent in brother and nephew with same phenotype</td>
<td align="left" colspan="1" rowspan="1">In 8/110 Swedish Controls</td>
<td align="left" colspan="1" rowspan="1">Transactivation activity on Hes3 similar to WT</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>7</bold>. Chen <italic>et al</italic>., 2010 [<xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 11 males</td>
<td align="left" colspan="1" rowspan="1">c.1075C&gt;T, P359S, rs41313406</td>
<td align="left" colspan="1" rowspan="1">Hypospadias</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Weak association with hypospadias by screening in a case-control SNP-genotyping study</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>7</bold>. Kalfa <italic>et al</italic>., 2011 [<xref ref-type="bibr" rid="pone.0142831.ref005">5</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 17 males (17/150)</td>
<td align="left" colspan="1" rowspan="1">c.1075C&gt;T, P359S, rs41313406</td>
<td align="left" colspan="1" rowspan="1">Hypospadias</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">Transactivation activity on Hes3 similar to WT</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>8</bold>. Lim <italic>et al</italic>., 2013 [<xref ref-type="bibr" rid="pone.0142831.ref031">31</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 1 male</td>
<td align="left" colspan="1" rowspan="1">c.1141C&gt;T, R371X</td>
<td align="left" colspan="1" rowspan="1">Normal</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Present in 1 control</td>
<td align="left" colspan="1" rowspan="1">Detected by exome sequencing in a study on autism</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>9</bold>. Kalfa <italic>et al</italic>., 2012 [<xref ref-type="bibr" rid="pone.0142831.ref006">6</xref>]</td>
<td align="left" colspan="1" rowspan="1">46,XY, 1 male</td>
<td align="left" colspan="1" rowspan="1">c.1151C&gt;T, P384L</td>
<td align="left" colspan="1" rowspan="1">Penile hypospadias, microphallus, intrascrotal testis</td>
<td align="left" colspan="1" rowspan="1">Slightly low LH, FSH. Low T, AMH, inhibin</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Maternal diabetes</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Reduced transactivation activity on Hes3</td>
<td align="left" colspan="1" rowspan="1">N: <italic>AR</italic>, <italic>SRD5A2</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>10</bold>. Kalfa <italic>et al</italic>., 2008 [<xref ref-type="bibr" rid="pone.0142831.ref004">4</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 1 male</td>
<td align="left" colspan="1" rowspan="1">c.1514T&gt;C, V505A, rs61740566</td>
<td align="left" colspan="1" rowspan="1">Isolated proximal hypospadias, intrascrotal testis</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>10</bold>. Zhang <italic>et al</italic>., 2010 [<xref ref-type="bibr" rid="pone.0142831.ref018">18</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, Neandertal</td>
<td align="left" colspan="1" rowspan="1">c.1514T&gt;C, V505A, rs61740566</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>10</bold>. Brandao <italic>et al</italic>., 2011 [<xref ref-type="bibr" rid="pone.0142831.ref011">11</xref>]</td>
<td align="left" colspan="1" rowspan="1">46,XX DSD (GD), 1 female</td>
<td align="left" colspan="1" rowspan="1">V505A, homozygote, rs61740566, (GOF)</td>
<td align="left" colspan="1" rowspan="1">Primary amenorrhea, no breast development, eunuchoid habitus, absence hirsutism, Tanner IV pubic hair, clitoromegaly, 2 perineal openings, unpalpable gonads. Bilateral streak gonads, small uterus, bilateral Fallopian tubes.</td>
<td align="left" colspan="1" rowspan="1">FSH eleated, normal LH, Prog, 17OH-Prog, androstenedione, T non increasing after hCG stimulation. <underline>Histology</underline>: absence of left gonad; fallopian tubes and a dysgenetic right gonad with hilar cell hyperplasia and persistence of Wolffian rests</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Parents are first cousins</td>
<td align="left" colspan="1" rowspan="1">Absent in 190 normal alleles</td>
<td align="left" colspan="1" rowspan="1">Transactivation activity on Hes3 and Hes7 higher than WT</td>
<td align="left" colspan="1" rowspan="1">N: <italic>FOXL2</italic>, <italic>BMP15</italic>, <italic>STRA8</italic>, <italic>Nanos1</italic>, <italic>Nanos2</italic>, <italic>NR5A1</italic>, <italic>Wnt4</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>10</bold>. Chen <italic>et al</italic>., 2010 [<xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 1 Male</td>
<td align="left" colspan="1" rowspan="1">c.1514T&gt;C, V505A, rs61740566</td>
<td align="left" colspan="1" rowspan="1">Hypospadias</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">Not located in the conserved site of the protein</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>11</bold>. Fukami <italic>et al</italic>., 2006 [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>]; Fukami <italic>et al</italic>., 2008 [<xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 2 male brothers</td>
<td align="left" colspan="1" rowspan="1">c.1739A&gt;G, Q580R</td>
<td align="left" colspan="1" rowspan="1">Female genitalia</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Italian origin. Absent in nephew with same phenotype</td>
<td align="left" colspan="1" rowspan="1">Absent in 200 European controls</td>
<td align="left" colspan="1" rowspan="1">Transactivation activity on Hes3 equal or higher than WT</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>12</bold>. Chen <italic>et al</italic>., 2010 [<xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 1 male</td>
<td align="left" colspan="1" rowspan="1">c.1804C&gt;A, Q602K, rs142908182</td>
<td align="left" colspan="1" rowspan="1">Severe hypospadias</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>13</bold>. Chen <italic>et al</italic>., 2010 [<xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 3 males</td>
<td align="left" colspan="1" rowspan="1">c.604ins3Q</td>
<td align="left" colspan="1" rowspan="1">Penoscrotal hypospadias, micropenis/chordee</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>14</bold>. Kalfa <italic>et al</italic>., 2008 [<xref ref-type="bibr" rid="pone.0142831.ref004">4</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 1 male</td>
<td align="left" colspan="1" rowspan="1">c.1810ins3Q, 614ins3Q</td>
<td align="left" colspan="1" rowspan="1">Isolated coronal hypospadias, intrascrotal testes</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>15</bold>. Fukami <italic>et al</italic>., 2006 [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>]; Fukami <italic>et al</italic>., 2008 [<xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 3 patients</td>
<td align="left" colspan="1" rowspan="1">c.1985A&gt;G, N662S, rs2073043</td>
<td align="left" colspan="1" rowspan="1">DSD</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">2 Japanese and 1 European origin</td>
<td align="left" colspan="1" rowspan="1">In 4 Japanese controls</td>
<td align="left" colspan="1" rowspan="1">Transactivation activity on Hes3 similar to WT</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>15</bold>. Chen <italic>et al</italic>., 2010 [<xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 11 males</td>
<td align="left" colspan="1" rowspan="1">c.1985A&gt;G, N662S, rs2073043</td>
<td align="left" colspan="1" rowspan="1">Hypospadias ranging from perineal to cleaved prepuce</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Association with hypospadias by screening in a case-control SNP-genotyping study</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>15</bold>. Kalfa <italic>et al</italic>., 2012 [<xref ref-type="bibr" rid="pone.0142831.ref006">6</xref>]</td>
<td align="left" colspan="1" rowspan="1">?</td>
<td align="left" colspan="1" rowspan="1">c.1985A&gt;G, N662S, rs2073043</td>
<td align="left" colspan="1" rowspan="1">Non-syndromic DSD</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>15</bold>. Kalfa <italic>et al</italic>., 2011 [<xref ref-type="bibr" rid="pone.0142831.ref005">5</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, males (22/150)</td>
<td align="left" colspan="1" rowspan="1">c.1985A&gt;G, N662S, rs2073043</td>
<td align="left" colspan="1" rowspan="1">Hypospadias</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">Transactivation activity on Hes3 similar to WT</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>7 + 15</bold>. Kalfa <italic>et al</italic>., 2011 [<xref ref-type="bibr" rid="pone.0142831.ref005">5</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, males (16/150)</td>
<td align="left" colspan="1" rowspan="1">P359S+N662S</td>
<td align="left" colspan="1" rowspan="1">Hypospadias</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">Transactivation activity on Hes3 similar to WT</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>7 + 15</bold>. Kalfa <italic>et al</italic>., 2012 [<xref ref-type="bibr" rid="pone.0142831.ref006">6</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 14 males</td>
<td align="left" colspan="1" rowspan="1">P359S+N662S</td>
<td align="left" colspan="1" rowspan="1">
<underline>3 cases</underline>: penile posterior hypospadias, cryptorchidism; <underline>5 cases</underline>: hypospadias, microphallus; <underline>6 cases</underline>: cryptorchidism, microphallus</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Combined data: incidence of P359S-N662S is higher in DSDs</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>7 + 15</bold>. Gaspari <italic>et al</italic>., 2011 [<xref ref-type="bibr" rid="pone.0142831.ref012">12</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 1 male</td>
<td align="left" colspan="1" rowspan="1">P359S+N662S</td>
<td align="left" colspan="1" rowspan="1">Right cryptorchidism, penis 1.5 cm (2.9 mo)</td>
<td align="left" colspan="1" rowspan="1">Normal androgen production</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">French with Mediterranian origin</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Study to evaluate effect of prenatal exposure to environmental endocrine disruptors</td>
<td align="left" colspan="1" rowspan="1">N: <italic>AR</italic>, <italic>SRD5A2</italic>, <italic>NR5A1</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>16</bold>. Ruiz-Arana <italic>et al</italic>., 2015 [<xref ref-type="bibr" rid="pone.0142831.ref010">10</xref>]</td>
<td align="left" colspan="1" rowspan="1">46,XY, (1/35 DSD ambiguous genitalia), 1 female</td>
<td align="left" colspan="1" rowspan="1">c.2030C&gt;T, P677L</td>
<td align="left" colspan="1" rowspan="1">Complete gonadal dysgenesis, external female genitalia, no gonads detected, uterus present, primary amenorrhea (13y).</td>
<td align="left" colspan="1" rowspan="1">FSH and LH elevated at diagnosis, estrogen low, testosterone normal</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Mother heterozygous (normal phenotype), father WT. No family history of DSD</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Abolished transactivation activity on Hes3</td>
<td align="left" colspan="1" rowspan="1">N: <italic>SRY</italic>, <italic>NR5A1</italic>, <italic>WT1</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>17</bold>. Fukami <italic>et al</italic>., 2006 [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>]; Fukami <italic>et al</italic>., 2008 [<xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, 1 male</td>
<td align="left" colspan="1" rowspan="1">c.2176C&gt;T, R726X rs121909495</td>
<td align="left" colspan="1" rowspan="1">Penoscrotal hypospadias, retractile testes, penis 1.2 cm</td>
<td align="left" colspan="1" rowspan="1">Normal</td>
<td align="left" colspan="1" rowspan="1">Normal</td>
<td align="left" colspan="1" rowspan="1">Japanese origin. Mother heterozygous.</td>
<td align="left" colspan="1" rowspan="1">Absent in 150 Japanese males</td>
<td align="left" colspan="1" rowspan="1">Causes non-mediated RNA decay. Reduced leukocyte transcripts. Transactivation activity on Hes3 similar to WT, protein expression similar to WT</td>
<td align="left" colspan="1" rowspan="1">N: <italic>AR</italic>, <italic>SRD5A2</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>18</bold>. Igarashi <italic>et al</italic>., 2015 [<xref ref-type="bibr" rid="pone.0142831.ref009">9</xref>]</td>
<td align="left" colspan="1" rowspan="1">46,XY, 1 male (1/180)</td>
<td align="left" colspan="1" rowspan="1">c.2041-2A&gt;G, K682fsX1070</td>
<td align="left" colspan="1" rowspan="1">Penoscrotal hypospadias, scrotal testes</td>
<td align="left" colspan="1" rowspan="1">Normal T, LH and FSH (2y 11 m)</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Reduced transactivation activity on Hes3. Reduced mutant protein expression.</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>19</bold>. Chen <italic>et al</italic>., 2010 [<xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, male</td>
<td align="left" colspan="1" rowspan="1">c.2277C&gt;T, D759D</td>
<td align="left" colspan="1" rowspan="1">Hypospadias</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>20</bold>. Chen <italic>et al</italic>., 2010 [<xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>]</td>
<td align="left" colspan="1" rowspan="1">?, male</td>
<td align="left" colspan="1" rowspan="1">c.2284+8A&gt;T</td>
<td align="left" colspan="1" rowspan="1">Hypospadias</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>21</bold>. Hu <italic>et al</italic>., 1996 [<xref ref-type="bibr" rid="pone.0142831.ref001">1</xref>]; Laporte <italic>et al</italic>., 1997 [<xref ref-type="bibr" rid="pone.0142831.ref002">2</xref>]</td>
<td align="left" colspan="1" rowspan="1">1 male, 46,XY</td>
<td align="left" colspan="1" rowspan="1">Microdeletion including MAMLD1-MTM1, 5’MAMLD1 gene deletion</td>
<td align="left" colspan="1" rowspan="1">Hypospadias, enlarged clitoris/micropenis, bifid scrotum, non- palpable testes. Introitus vagina and vaginal pouch.</td>
<td align="left" colspan="1" rowspan="1">Normal 17OHProgesterone, 21DOC, androstenedione, testosterone, dihydrotestosterone, FSH and LH levels</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>22</bold>. Hu <italic>et al</italic>., 1996 [<xref ref-type="bibr" rid="pone.0142831.ref001">1</xref>]; Laporte <italic>et al</italic>., 1997 [<xref ref-type="bibr" rid="pone.0142831.ref002">2</xref>]</td>
<td align="left" colspan="1" rowspan="1">1 male, 46,XY</td>
<td align="left" colspan="1" rowspan="1">Microdeletion including MAMLD1-MTM1, whole MAMLD1 gene deletion</td>
<td align="left" colspan="1" rowspan="1">Perineoscrotal hypospadias. Neuromuscular disorder</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>23</bold>. Bartsch <italic>et al</italic>., 1999 [<xref ref-type="bibr" rid="pone.0142831.ref028">28</xref>]</td>
<td align="left" colspan="1" rowspan="1">3 males: 2 babies and 1 fetus</td>
<td align="left" colspan="1" rowspan="1">Microdeletion including MAMLD1-MTM1, whole MAMLD1 gene deletion</td>
<td align="left" colspan="1" rowspan="1">1<sup>st</sup>: abnormal genitalia (undescended right testis and glandular hypospadias) and extreme muscular hypotonia; 2<sup>nd</sup>: bilateral cryptorchidism, penile hypospadias and extreme muscular hypotonia; 3<sup>rd</sup> (terminated 13 WG): penile hypospadias.</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Mother asthenic, low muscle power and irregular menses</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>24</bold>. Tsai <italic>et al</italic>., 2005 [<xref ref-type="bibr" rid="pone.0142831.ref029">29</xref>]</td>
<td align="left" colspan="1" rowspan="1">1 male</td>
<td align="left" colspan="1" rowspan="1">Microdeletion: deletion MAMLD1ex6-8-MTMR1ex1-2, resulting in a fusion MAMLD1-MTMR1</td>
<td align="left" colspan="1" rowspan="1">Without DSD. Myotubular myopathy</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Japanese origin</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<bold>25</bold>. Oliveira <italic>et al</italic>., 2013 [<xref ref-type="bibr" rid="pone.0142831.ref030">30</xref>]</td>
<td align="left" colspan="1" rowspan="1">1 male</td>
<td align="left" colspan="1" rowspan="1">Complex rearrangement including the whole MAMLD1 gene and a fusion 5’MTM1-3’MAMLD1+MTM1</td>
<td align="left" colspan="1" rowspan="1">Without DSD. Myotubular myopathy</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001">
<p>
<sup>a</sup> the variants were named according to NM_005491.4.</p>
</fn>
<fn id="t003fn002">
<p>N: normal sequence; NA: not analyzed; ?/-: unknown; GD: gonadal dysgenesis; GOF: gain of function.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>To test novel MAMLD1 sequence variations for their disease causing role, we used <italic>Hes3</italic> promoter activation assays as previously performed for other mutations in other laboratories. In addition, we tested for <italic>CYP17A1</italic> promoter activation and an effect on steroid enzyme activity as well as for variable expression of WT and mutant MAMLD1 proteins. Overall, all these studies were not giving conclusive results to explain the role of MAMLD1 gene variants for abnormal sex development. Similar confounding results for functional studies are found in the published literature [<xref ref-type="table" rid="pone.0142831.t003">Table 3</xref> and [<xref ref-type="bibr" rid="pone.0142831.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0142831.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>]]. Although studies in mice revealed a role of MAMLD1 for <italic>Cyp17</italic> gene expression and activity [<xref ref-type="bibr" rid="pone.0142831.ref013">13</xref>], our WT MAMLD1 was only able to modulate the human <italic>CYP17A1</italic> promoter activity, but had no effect on steroid conversion and thus enzyme activity. Human MAMLD1 does not bind to the <italic>Hes3</italic> promoter or to the human <italic>HES3</italic> upstream region directly [<xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>]. Therefore, it has been proposed that MAMLD1 may act through other partners such as the Hes3-DNA-binding transcription factor [<xref ref-type="bibr" rid="pone.0142831.ref014">14</xref>], but to date such partners remain obscure. Our <italic>in silico</italic> search for possible interacting partners of human MAMLD1 was negative when using tools to search for functional partners (<ext-link ext-link-type="uri" xlink:href="http://string-db.org">string-db.org</ext-link>) or for physical or genetic interactions (<ext-link ext-link-type="uri" xlink:href="http://thebiogrid.org">http://thebiogrid.org</ext-link>).</p>
<p>To date, twenty-seven <italic>MAMLD1</italic> sequence variations are described, including the 7 novel variants described in this study (Tables <xref ref-type="table" rid="pone.0142831.t001">1</xref> and <xref ref-type="table" rid="pone.0142831.t003">3</xref>). They are all located between exon 4 and intron 6 (<xref ref-type="fig" rid="pone.0142831.g001">Fig 1B</xref>) and show the following genotype-phenotype characteristics. Most mutations are only found in DSD patients which present with a broad range of mild to severe phenotype [c325delG (6), S143X [<xref ref-type="bibr" rid="pone.0142831.ref006">6</xref>], E182fsX121 [<xref ref-type="bibr" rid="pone.0142831.ref004">4</xref>], E197X, [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>], T202M (present study), L210X and D211N (present study), Q270X, [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>], H347Q [<xref ref-type="bibr" rid="pone.0142831.ref006">6</xref>] (present study), P384L [<xref ref-type="bibr" rid="pone.0142831.ref006">6</xref>], Q501Q502 (present study), A503E (present study), Q580R [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>], Q602K [<xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>], K682fsX1070 [<xref ref-type="bibr" rid="pone.0142831.ref009">9</xref>], 614ins3Q [<xref ref-type="bibr" rid="pone.0142831.ref004">4</xref>], P677L [<xref ref-type="bibr" rid="pone.0142831.ref010">10</xref>], L724V (present study), R726X, [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>], S730S (present study), D759D [<xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>]]. Others are carried by patients and controls [P359S [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0142831.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>] (present study), V505A [<xref ref-type="bibr" rid="pone.0142831.ref004">4</xref>, <xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>] (present study), 604ins3Q [<xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>], N662S [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0142831.ref005">5</xref>–<xref ref-type="bibr" rid="pone.0142831.ref007">7</xref>] (present study)]. MAMLD1 R371X is only described in a control [<xref ref-type="bibr" rid="pone.0142831.ref031">31</xref>]. Finally, in two independent families MAMLD1 mutations [P359S and Q580R [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>]] were not found in all 46,XY DSD family members. Thus, genotype-phenotype correlation of MAMLD1 sequence variations and 46,XY DSD is poor.</p>
<p>
<italic>MAMLD1</italic> gene variations are also reported in other species, both male and female, and with and without abnormalities in sex development [<xref ref-type="bibr" rid="pone.0142831.ref015">15</xref>–<xref ref-type="bibr" rid="pone.0142831.ref017">17</xref>]. Yet none of them has been clearly related to the DSD phenotype. In dogs, both DSD and controls were carriers [<xref ref-type="bibr" rid="pone.0142831.ref015">15</xref>], in cats only an intronic change has been described [<xref ref-type="bibr" rid="pone.0142831.ref016">16</xref>], and in a male horse with hypospadias a benign mutation was detected, conserved in all <italic>MAMLD1</italic> sequences available at that time [<xref ref-type="bibr" rid="pone.0142831.ref017">17</xref>].</p>
<p>MAMLD1 seems involved in sexual development during fetal life. It is expressed in human fetal testes and ovaries [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0142831.ref032">32</xref>], and in mice testes [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0142831.ref013">13</xref>]. <italic>Mamld1</italic> is present in mice testes at least from E11.5 which overlaps with the start of androgen biosynthesis (13 dpc) and with the formation of the male external genitalia (16.5 dpc) [<xref ref-type="bibr" rid="pone.0142831.ref013">13</xref>]. <italic>Mamld1</italic> is expressed at low levels in postnatal mice testes until 1 week of age [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0142831.ref033">33</xref>]. In human fetal testes, MAMLD1 is expressed at high levels in the second trimester of gestation [<xref ref-type="bibr" rid="pone.0142831.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0142831.ref032">32</xref>]. In addition, our study shows that it is also expressed in human adult testes and adrenals, but not in fetal adrenal tissue. These results suggest that MAMLD1 may not only have a role during fetal development but also in adult life.</p>
<p>In mice, Mamld1 regulates the expression of steroidogenic enzymes <italic>Cyp17a1</italic>, <italic>Cyp11a1</italic>, <italic>Star</italic>, <italic>Hsd3b1</italic>, <italic>Hsd17b3</italic>, and of genes involved in testes descent (<italic>Amh</italic> and <italic>Insl3</italic>) [<xref ref-type="bibr" rid="pone.0142831.ref013">13</xref>, <xref ref-type="bibr" rid="pone.0142831.ref020">20</xref>]. It seems involved in testosterone production by regulating Cyp17a1 activity and expression [<xref ref-type="bibr" rid="pone.0142831.ref020">20</xref>]. However, <italic>Mamld1</italic>-KO mice develop normal external genitalia and have normal reproduction, which both depend on testosterone production and Cyp17 activity [<xref ref-type="bibr" rid="pone.0142831.ref013">13</xref>]. Overall, these results challenge the role of MAMLD1 in sex development.</p>
<p>In conclusion, the importance of MAMLD1 in the sexual development becomes less and less clear. Its exact role remains unknown. Studies of MAMLD1 variations in humans suggest that there is a genetic correlation between MAMLD1 sequence variations and DSD. However, the wide range in phenotype and poor genotype-phenotype correlation indicate that MAMLD1 gene variations may not suffice to explain the DSD pathology. Therefore, in DSD patients harboring MAMLD1 sequence variations further genetic studies should be performed searching for additional genetic hits explaining the immense variability. This may be done by specific DSD chips containing a larger array of known genes involved in DSD, which are currently being used in several DSD research projects and should become available soon. Alternatively, an untargeted approach like exome sequencing might be employed that also allows to find novel genes so far unrevealed in DSD [<xref ref-type="bibr" rid="pone.0142831.ref034">34</xref>]. In addition, to find copy number variations array-based comparative genomic hybridization (aCGH) or multiplex ligation-dependent probe amplification (MLPA) may be used [<xref ref-type="bibr" rid="pone.0142831.ref035">35</xref>]. Although so far no multiple hits in DSD genes were described involving MAMLD1, it would not be surprising to find them in the near future with the above mentioned next generation methods.</p>
</sec>
<sec id="sec019" sec-type="supplementary-material">
<title>Supporting Information</title>
<supplementary-material content-type="local-data" id="pone.0142831.s001">
<label>S1 Fig</label>
<caption>
<title>MAMLD1 alignment in mammalian species.</title>
<p>Human MAMLD1 (isoform 2, 774 amino acids) was aligned with homologous sequences from 40 mammalian species (length range from 720–820 amino acids). L210 and L724 (1 change each) are conserved along mammalian evolution, followed by S730 (deleted amino acid in 2 species). T202, D211, P359, Q501Q502, A503, V505 and N662 are not conserved, all ranging from 1 to 6 changes. Human changes in positions 202, 347, 505 and 662 present WT in other mammals. The alignments were performed with the CLC Sequence Viewer software (2014 CLC bio, QIAGEN) and show the species common name and the NCBI database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">www.ncbi.nlm.nih.gov</ext-link>) accession name/s in brackets. Human: <italic>Homo sapiens</italic>; chimpanzee: <italic>Pan troglodytes</italic>; pygmy chimpanzee: <italic>Pan paniscus</italic>; western lowland gorilla: <italic>Gorilla gorilla gorilla</italic>; crab-eating macaque: <italic>Macaca fascicularis</italic>; pig-tailed macaque: <italic>Macaca nemestrina</italic>; sooty mangabey: <italic>Cercocebus atys</italic>; green monkey: <italic>Chlorocebus sabaeus</italic>; white-tufted-ear marmoset: <italic>Callithrix jacchus</italic>; small-eared galago: <italic>Otolemur garnettii</italic>; Sunda flying lemur: <italic>Galeopterus variegatus</italic>; Chinese tree shrew: <italic>Tupaia chinensis</italic>; Cape golden mole: <italic>Chrysochloris asiatica</italic>; thirteen-lined ground squirrel: <italic>Ictidomys tridecemlineatus</italic>; rabbit: <italic>Oryctolagus cuniculus</italic>; American pika: <italic>Ochotona princeps</italic>; house mouse: <italic>Mus musculus</italic>; prairie deer mouse: <italic>Peromyscus maniculatus bairdii</italic>; Chinese hamster: <italic>Cricetulus griseus</italic>; prairie vole: <italic>Microtus ochrogaster</italic>; Damara mole-rat: <italic>Fukomis damarensis</italic>; Iesser Egyptian jerboa: <italic>Jaculus jaculus</italic>; big brown bat: <italic>Eptesicus fuscus</italic>; horse: <italic>Equus caballus</italic>; Bactrian camel: <italic>Camelus bactrianus</italic>; dog: <italic>Canis lupus familiaris</italic>; alpaca: <italic>Vicugna pacos</italic>; pig: <italic>Sus scrofa</italic>; southern white rhinoceros: <italic>Ceratotherium simum simum</italic>; Pacific walrus: <italic>Odobenus rosmarus divergens</italic>; bottlenosed dolphin: <italic>Tursiops truncatus</italic>; Yangtze River dolphin: <italic>Lipotes vexillifer</italic>; Florida manatee: <italic>Trichechus manatus latirostris</italic>; killer whale: <italic>Orcinus orca</italic>; sperm whale: <italic>Physeter catodon</italic>; sheep: <italic>Ovis aries</italic>; goat: <italic>Capra hircus</italic>; chiru: <italic>Pantholops hodgsonii</italic>; cattle: <italic>Bos taurus</italic>; water buffalo: <italic>Bubalus bubalis</italic>; nine-banded armadillo: <italic>Dasypus novemcinctus</italic>.</p>
<p>(PDF)</p>
</caption>
<media xlink:href="pone.0142831.s001.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0142831.s002">
<label>S2 Fig</label>
<caption>
<title>Effect of WT and mutant MAMLD1 on CYP17A1 enzyme activity in HEK293 and MA-10 cells.</title>
<p>Cells were transiently transfected with MAMLD1 WT and mutant expression vectors. HEK293 cells were also co-transfected with the CYP17A1 expression vector as they do not express it endogenously. The effect of WT and mutant MAMLD1 on CYP17A1 enzyme activity was assessed by measuring the conversion of progesterone (P) to 17-hydroxyprogesterone (17OHP) in non-steroidogenic HEK293 cells, and conversion of P to 17OHP and then to androstenedione (Δ4A) in steroidogenic mouse Leydig MA-10 cells. Steroid production was labeled with [<sup>14</sup>C]progesterone for 60 min. Steroids were extracted and resolved by thin-layer chromatography, then quantified as % conversion. A representative steroid profile obtained from HEK293 (A) and MA-10 (B) cells is shown (n = 2). Similar to experiments performed in NCI-H295R cells (<xref ref-type="fig" rid="pone.0142831.g003">Fig 3B</xref>), no effect of MAMLD1 on CYP17-hydroxylase activity was detected. Ve: empty vector; WT: wild type; *: co-transfected with empty vector; NT: non-transfected.</p>
<p>(TIF)</p>
</caption>
<media xlink:href="pone.0142831.s002.tif">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0142831.s003">
<label>S3 Fig</label>
<caption>
<title>Protein expression of MAMLD1.</title>
<p>Picture of the original uncropped and unadjusted Western blots for myc-MAMLD1 (A) and actin (B) corresponding to <xref ref-type="fig" rid="pone.0142831.g004">Fig 4</xref>. Ve: empty vector; WT: wild type; NT: non-transfected.</p>
<p>(TIF)</p>
</caption>
<media xlink:href="pone.0142831.s003.tif">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0142831.s004">
<label>S1 File</label>
<caption>
<title>Relevant experimental data.</title>
<p>Data corresponding to the transactivation studies are provided, which include: raw data from the luciferase assays, values behind statistics and original graphs.</p>
<p>(XLSX)</p>
</caption>
<media xlink:href="pone.0142831.s004.xlsx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0142831.s005">
<label>S1 Table</label>
<caption>
<title>Primers used in this study.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0142831.s005.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We acknowledge the patients and families. We thank Pilar Andaluz and Drs Amit V Pandey, Sameer Udhane, Maki Fukami and Emmanuel Christ for making this study possible.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0142831.ref001">
<label>1</label>
<mixed-citation publication-type="journal">
<name><surname>Hu</surname><given-names>LJ</given-names></name>, <name><surname>Laporte</surname><given-names>J</given-names></name>, <name><surname>Kress</surname><given-names>W</given-names></name>, <name><surname>Kioschis</surname><given-names>P</given-names></name>, <name><surname>Siebenhaar</surname><given-names>R</given-names></name>, <name><surname>Poustka</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Deletions in Xq28 in two boys with myotubular myopathy and abnormal genital development define a new contiguous gene syndrome in a 430 kb region</article-title>. <source/>Human molecular genetics. <year>1996</year>;<volume>5</volume>(<issue>1</issue>):<fpage>139</fpage>–<lpage>43</lpage>. Epub 1996/01/01. .<pub-id pub-id-type="pmid">8789451</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref002">
<label>2</label>
<mixed-citation publication-type="journal">
<name><surname>Laporte</surname><given-names>J</given-names></name>, <name><surname>Kioschis</surname><given-names>P</given-names></name>, <name><surname>Hu</surname><given-names>LJ</given-names></name>, <name><surname>Kretz</surname><given-names>C</given-names></name>, <name><surname>Carlsson</surname><given-names>B</given-names></name>, <name><surname>Poustka</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Cloning and characterization of an alternatively spliced gene in proximal Xq28 deleted in two patients with intersexual genitalia and myotubular myopathy</article-title>. <source/>Genomics. <year>1997</year>;<volume>41</volume>(<issue>3</issue>):<fpage>458</fpage>–<lpage>62</lpage>. Epub 1997/05/01. <pub-id pub-id-type="doi">10.1006/geno.1997.4662</pub-id>
.<pub-id pub-id-type="pmid">9169146</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref003">
<label>3</label>
<mixed-citation publication-type="journal">
<name><surname>Fukami</surname><given-names>M</given-names></name>, <name><surname>Wada</surname><given-names>Y</given-names></name>, <name><surname>Miyabayashi</surname><given-names>K</given-names></name>, <name><surname>Nishino</surname><given-names>I</given-names></name>, <name><surname>Hasegawa</surname><given-names>T</given-names></name>, <name><surname>Nordenskjold</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>CXorf6 is a causative gene for hypospadias</article-title>. <source/>Nature genetics. <year>2006</year>;<volume>38</volume>(<issue>12</issue>):<fpage>1369</fpage>–<lpage>71</lpage>. Epub 2006/11/07. <pub-id pub-id-type="doi">10.1038/ng1900</pub-id>
.<pub-id pub-id-type="pmid">17086185</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref004">
<label>4</label>
<mixed-citation publication-type="journal">
<name><surname>Kalfa</surname><given-names>N</given-names></name>, <name><surname>Liu</surname><given-names>B</given-names></name>, <name><surname>Klein</surname><given-names>O</given-names></name>, <name><surname>Audran</surname><given-names>F</given-names></name>, <name><surname>Wang</surname><given-names>MH</given-names></name>, <name><surname>Mei</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Mutations of CXorf6 are associated with a range of severities of hypospadias</article-title>. <source/>European journal of endocrinology / European Federation of Endocrine Societies. <year>2008</year>;<volume>159</volume>(<issue>4</issue>):<fpage>453</fpage>–<lpage>8</lpage>. Epub 2008/07/19. <pub-id pub-id-type="doi">10.1530/EJE-08-0085</pub-id>
.<pub-id pub-id-type="pmid">18635673</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref005">
<label>5</label>
<mixed-citation publication-type="journal">
<name><surname>Kalfa</surname><given-names>N</given-names></name>, <name><surname>Cassorla</surname><given-names>F</given-names></name>, <name><surname>Audran</surname><given-names>F</given-names></name>, <name><surname>Oulad Abdennabi</surname><given-names>I</given-names></name>, <name><surname>Philibert</surname><given-names>P</given-names></name>, <name><surname>Beroud</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Polymorphisms of MAMLD1 gene in hypospadias</article-title>. <source/>Journal of pediatric urology. <year>2011</year>;<volume>7</volume>(<issue>6</issue>):<fpage>585</fpage>–<lpage>91</lpage>. Epub 2011/10/28. <pub-id pub-id-type="doi">10.1016/j.jpurol.2011.09.005</pub-id>
.<pub-id pub-id-type="pmid">22030455</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref006">
<label>6</label>
<mixed-citation publication-type="journal">
<name><surname>Kalfa</surname><given-names>N</given-names></name>, <name><surname>Fukami</surname><given-names>M</given-names></name>, <name><surname>Philibert</surname><given-names>P</given-names></name>, <name><surname>Audran</surname><given-names>F</given-names></name>, <name><surname>Pienkowski</surname><given-names>C</given-names></name>, <name><surname>Weill</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Screening of MAMLD1 mutations in 70 children with 46,XY DSD: identification and functional analysis of two new mutations</article-title>. <source/>PloS one. <year>2012</year>;<volume>7</volume>(<issue>3</issue>):<fpage>e32505</fpage> Epub 2012/04/06. <pub-id pub-id-type="doi">10.1371/journal.pone.0032505</pub-id>
<pub-id pub-id-type="pmid">22479329</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref007">
<label>7</label>
<mixed-citation publication-type="journal">
<name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Thai</surname><given-names>HT</given-names></name>, <name><surname>Lundin</surname><given-names>J</given-names></name>, <name><surname>Lagerstedt-Robinson</surname><given-names>K</given-names></name>, <name><surname>Zhao</surname><given-names>S</given-names></name>, <name><surname>Markljung</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Mutational study of the MAMLD1-gene in hypospadias</article-title>. <source/>European journal of medical genetics. <year>2010</year>;<volume>53</volume>(<issue>3</issue>):<fpage>122</fpage>–<lpage>6</lpage>. Epub 2010/03/30. <pub-id pub-id-type="doi">10.1016/j.ejmg.2010.03.005</pub-id>
.<pub-id pub-id-type="pmid">20347055</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref008">
<label>8</label>
<mixed-citation publication-type="journal">
<name><surname>Metwalley</surname><given-names>KA</given-names></name>, <name><surname>Farghaly</surname><given-names>HS</given-names></name>. <article-title>X-linked congenital adrenal hypoplasia associated with hypospadias in an Egyptian baby: a case report</article-title>. <source/>Journal of medical case reports. <year>2012</year>;<volume>6</volume>:<fpage>428</fpage> Epub 2013/01/01. <pub-id pub-id-type="doi">10.1186/1752-1947-6-428</pub-id>
<pub-id pub-id-type="pmid">23272655</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref009">
<label>9</label>
<mixed-citation publication-type="journal">
<name><surname>Igarashi</surname><given-names>M</given-names></name>, <name><surname>Wada</surname><given-names>Y</given-names></name>, <name><surname>Kojima</surname><given-names>Y</given-names></name>, <name><surname>Miyado</surname><given-names>M</given-names></name>, <name><surname>Nakamura</surname><given-names>M</given-names></name>, <name><surname>Muroya</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Novel Splice Site Mutation in MAMLD1 in a Patient with Hypospadias</article-title>. <source/>Sexual development: genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation. <year>2015</year> Epub 2015/04/03. <pub-id pub-id-type="doi">10.1159/000380842</pub-id>
.<pub-id pub-id-type="pmid">25833151</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref010">
<label>10</label>
<mixed-citation publication-type="journal">
<name><surname>Ruiz-Arana</surname><given-names>IL</given-names></name>, <name><surname>Hubner</surname><given-names>A</given-names></name>, <name><surname>Cetingdag</surname><given-names>C</given-names></name>, <name><surname>Krude</surname><given-names>H</given-names></name>, <name><surname>Gruters</surname><given-names>A</given-names></name>, <name><surname>Fukami</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>A Novel Hemizygous Mutation of MAMLD1 in a Patient with 46,XY Complete Gonadal Dysgenesis</article-title>. <source/>Sexual development: genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation. <year>2015</year> Epub 2015/02/11. <pub-id pub-id-type="doi">10.1159/000371603</pub-id>
.<pub-id pub-id-type="pmid">25660412</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref011">
<label>11</label>
<mixed-citation publication-type="journal">
<name><surname>Brandao</surname><given-names>MP</given-names></name>, <name><surname>Costa</surname><given-names>EM</given-names></name>, <name><surname>Fukami</surname><given-names>M</given-names></name>, <name><surname>Gerdulo</surname><given-names>M</given-names></name>, <name><surname>Pereira</surname><given-names>NP</given-names></name>, <name><surname>Domenice</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>MAMLD1 (mastermind-like domain containing 1) homozygous gain-of-function missense mutation causing 46,XX disorder of sex development in a virilized female</article-title>. <source/>Advances in experimental medicine and biology. <year>2011</year>;<volume>707</volume>:<fpage>129</fpage>–<lpage>31</lpage>. Epub 2011/06/22. <pub-id pub-id-type="doi">10.1007/978-1-4419-8002-1_28</pub-id>
.<pub-id pub-id-type="pmid">21691970</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref012">
<label>12</label>
<mixed-citation publication-type="journal">
<name><surname>Gaspari</surname><given-names>L</given-names></name>, <name><surname>Paris</surname><given-names>F</given-names></name>, <name><surname>Philibert</surname><given-names>P</given-names></name>, <name><surname>Audran</surname><given-names>F</given-names></name>, <name><surname>Orsini</surname><given-names>M</given-names></name>, <name><surname>Servant</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>'Idiopathic' partial androgen insensitivity syndrome in 28 newborn and infant males: impact of prenatal exposure to environmental endocrine disruptor chemicals?</article-title>
<source/>European journal of endocrinology / European Federation of Endocrine Societies. <year>2011</year>;<volume>165</volume>(<issue>4</issue>):<fpage>579</fpage>–<lpage>87</lpage>. Epub 2011/07/27. <pub-id pub-id-type="doi">10.1530/EJE-11-0580</pub-id>
.<pub-id pub-id-type="pmid">21788424</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref013">
<label>13</label>
<mixed-citation publication-type="journal">
<name><surname>Miyado</surname><given-names>M</given-names></name>, <name><surname>Nakamura</surname><given-names>M</given-names></name>, <name><surname>Miyado</surname><given-names>K</given-names></name>, <name><surname>Morohashi</surname><given-names>K</given-names></name>, <name><surname>Sano</surname><given-names>S</given-names></name>, <name><surname>Nagata</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Mamld1 deficiency significantly reduces mRNA expression levels of multiple genes expressed in mouse fetal Leydig cells but permits normal genital and reproductive development</article-title>. <source/>Endocrinology. <year>2012</year>;<volume>153</volume>(<issue>12</issue>):<fpage>6033</fpage>–<lpage>40</lpage>. Epub 2012/10/23. <pub-id pub-id-type="doi">10.1210/en.2012-1324</pub-id>
<pub-id pub-id-type="pmid">23087174</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref014">
<label>14</label>
<mixed-citation publication-type="journal">
<name><surname>Fukami</surname><given-names>M</given-names></name>, <name><surname>Wada</surname><given-names>Y</given-names></name>, <name><surname>Okada</surname><given-names>M</given-names></name>, <name><surname>Kato</surname><given-names>F</given-names></name>, <name><surname>Katsumata</surname><given-names>N</given-names></name>, <name><surname>Baba</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Mastermind-like domain-containing 1 (MAMLD1 or CXorf6) transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence</article-title>. <source/>The Journal of biological chemistry. <year>2008</year>;<volume>283</volume>(<issue>9</issue>):<fpage>5525</fpage>–<lpage>32</lpage>. Epub 2007/12/29. <pub-id pub-id-type="doi">10.1074/jbc.M703289200</pub-id>
.<pub-id pub-id-type="pmid">18162467</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref015">
<label>15</label>
<mixed-citation publication-type="journal">
<name><surname>Switonski</surname><given-names>M</given-names></name>, <name><surname>Payan-Carreira</surname><given-names>R</given-names></name>, <name><surname>Bartz</surname><given-names>M</given-names></name>, <name><surname>Nowacka-Woszuk</surname><given-names>J</given-names></name>, <name><surname>Szczerbal</surname><given-names>I</given-names></name>, <name><surname>Colaco</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Hypospadias in a male (78,XY; SRY-positive) dog and sex reversal female (78,XX; SRY-negative) dogs: clinical, histological and genetic studies</article-title>. <source/>Sexual development: genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation. <year>2012</year>;<volume>6</volume>(<issue>1–3</issue>):<fpage>128</fpage>–<lpage>34</lpage>. Epub 2011/09/07. <pub-id pub-id-type="doi">10.1159/000330921</pub-id>
.<pub-id pub-id-type="pmid">21893969</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref016">
<label>16</label>
<mixed-citation publication-type="journal">
<name><surname>Nowacka-Woszuk</surname><given-names>J</given-names></name>, <name><surname>Szczerbal</surname><given-names>I</given-names></name>, <name><surname>Salamon</surname><given-names>S</given-names></name>, <name><surname>Kociucka</surname><given-names>B</given-names></name>, <name><surname>Jackowiak</surname><given-names>H</given-names></name>, <name><surname>Prozorowska</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Testicular disorder of sex development in four cats with a male karyotype (38,XY; SRY-positive)</article-title>. <source/>Animal reproduction science. <year>2014</year>;<volume>151</volume>(<issue>1–2</issue>):<fpage>42</fpage>–<lpage>8</lpage>. Epub 2014/12/03. <pub-id pub-id-type="doi">10.1016/j.anireprosci.2014.10.001</pub-id>
.<pub-id pub-id-type="pmid">25455261</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref017">
<label>17</label>
<mixed-citation publication-type="journal">
<name><surname>De Lorenzi</surname><given-names>L</given-names></name>, <name><surname>Genualdo</surname><given-names>V</given-names></name>, <name><surname>Iannuzzi</surname><given-names>A</given-names></name>, <name><surname>Di Meo</surname><given-names>GP</given-names></name>, <name><surname>Perucatti</surname><given-names>A</given-names></name>, <name><surname>Mancuso</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Cytogenetic and genetic studies in a hypospadic horse (Equus caballus, 2n = 64)</article-title>. <source/>Sexual development: genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation. <year>2010</year>;<volume>4</volume>(<issue>6</issue>):<fpage>352</fpage>–<lpage>7</lpage>. Epub 2010/08/25. <pub-id pub-id-type="doi">10.1159/000319527</pub-id>
.<pub-id pub-id-type="pmid">20733278</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref018">
<label>18</label>
<mixed-citation publication-type="journal">
<name><surname>Zhang</surname><given-names>G</given-names></name>, <name><surname>Pei</surname><given-names>Z</given-names></name>, <name><surname>Krawczak</surname><given-names>M</given-names></name>, <name><surname>Ball</surname><given-names>EV</given-names></name>, <name><surname>Mort</surname><given-names>M</given-names></name>, <name><surname>Kehrer-Sawatzki</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Triangulation of the human, chimpanzee, and Neanderthal genome sequences identifies potentially compensated mutations</article-title>. <source/>Human mutation. <year>2010</year>;<volume>31</volume>(<issue>12</issue>):<fpage>1286</fpage>–<lpage>93</lpage>. Epub 2010/11/11. <pub-id pub-id-type="doi">10.1002/humu.21389</pub-id>
.<pub-id pub-id-type="pmid">21064102</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref019">
<label>19</label>
<mixed-citation publication-type="journal">
<name><surname>Kageyama</surname><given-names>R</given-names></name>, <name><surname>Ohtsuka</surname><given-names>T</given-names></name>, <name><surname>Kobayashi</surname><given-names>T</given-names></name>. <article-title>The Hes gene family: repressors and oscillators that orchestrate embryogenesis</article-title>. <source/>Development. <year>2007</year>;<volume>134</volume>(<issue>7</issue>):<fpage>1243</fpage>–<lpage>51</lpage>. Epub 2007/03/03. <pub-id pub-id-type="doi">10.1242/dev.000786</pub-id>
.<pub-id pub-id-type="pmid">17329370</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref020">
<label>20</label>
<mixed-citation publication-type="journal">
<name><surname>Nakamura</surname><given-names>M</given-names></name>, <name><surname>Fukami</surname><given-names>M</given-names></name>, <name><surname>Sugawa</surname><given-names>F</given-names></name>, <name><surname>Miyado</surname><given-names>M</given-names></name>, <name><surname>Nonomura</surname><given-names>K</given-names></name>, <name><surname>Ogata</surname><given-names>T</given-names></name>. <article-title>Mamld1 knockdown reduces testosterone production and Cyp17a1 expression in mouse Leydig tumor cells</article-title>. <source/>PloS one. <year>2011</year>;<volume>6</volume>(<issue>4</issue>):<fpage>e19123</fpage> Epub 2011/05/12. <pub-id pub-id-type="doi">10.1371/journal.pone.0019123</pub-id>
<pub-id pub-id-type="pmid">21559465</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref021">
<label>21</label>
<mixed-citation publication-type="journal">
<name><surname>Audi</surname><given-names>L</given-names></name>, <name><surname>Fernandez-Cancio</surname><given-names>M</given-names></name>, <name><surname>Carrascosa</surname><given-names>A</given-names></name>, <name><surname>Andaluz</surname><given-names>P</given-names></name>, <name><surname>Toran</surname><given-names>N</given-names></name>, <name><surname>Piro</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46,XY disorder of sex development</article-title>. <source/>The Journal of clinical endocrinology and metabolism. <year>2010</year>;<volume>95</volume>(<issue>4</issue>):<fpage>1876</fpage>–<lpage>88</lpage>. Epub 2010/02/13. <pub-id pub-id-type="doi">10.1210/jc.2009-2146</pub-id>
.<pub-id pub-id-type="pmid">20150575</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref022">
<label>22</label>
<mixed-citation publication-type="journal">
<name><surname>Fernandez-Cancio</surname><given-names>M</given-names></name>, <name><surname>Audi</surname><given-names>L</given-names></name>, <name><surname>Andaluz</surname><given-names>P</given-names></name>, <name><surname>Toran</surname><given-names>N</given-names></name>, <name><surname>Piro</surname><given-names>C</given-names></name>, <name><surname>Albisu</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>SRD5A2 gene mutations and polymorphisms in Spanish 46,XY patients with a disorder of sex differentiation</article-title>. <source/>International journal of andrology. <year>2011</year>;<volume>34</volume>(<issue>6 Pt 2</issue>):<fpage>e526</fpage>–<lpage>35</lpage>. Epub 2011/06/03. <pub-id pub-id-type="doi">10.1111/j.1365-2605.2010.01136.x</pub-id>
.<pub-id pub-id-type="pmid">21631525</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref023">
<label>23</label>
<mixed-citation publication-type="journal">
<name><surname>Camats</surname><given-names>N</given-names></name>, <name><surname>Pandey</surname><given-names>AV</given-names></name>, <name><surname>Fernandez-Cancio</surname><given-names>M</given-names></name>, <name><surname>Andaluz</surname><given-names>P</given-names></name>, <name><surname>Janner</surname><given-names>M</given-names></name>, <name><surname>Toran</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Ten novel mutations in the NR5A1 gene cause disordered sex development in 46,XY and ovarian insufficiency in 46,XX individuals</article-title>. <source/>The Journal of clinical endocrinology and metabolism. <year>2012</year>;<volume>97</volume>(<issue>7</issue>):<fpage>E1294</fpage>–<lpage>306</lpage>. Epub 2012/05/03. <pub-id pub-id-type="doi">10.1210/jc.2011-3169</pub-id>
.<pub-id pub-id-type="pmid">22549935</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref024">
<label>24</label>
<mixed-citation publication-type="journal">
<name><surname>Nishimura</surname><given-names>M</given-names></name>, <name><surname>Isaka</surname><given-names>F</given-names></name>, <name><surname>Ishibashi</surname><given-names>M</given-names></name>, <name><surname>Tomita</surname><given-names>K</given-names></name>, <name><surname>Tsuda</surname><given-names>H</given-names></name>, <name><surname>Nakanishi</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Structure, chromosomal locus, and promoter of mouse Hes2 gene, a homologue of Drosophila hairy and Enhancer of split</article-title>. <source/>Genomics. <year>1998</year>;<volume>49</volume>(<issue>1</issue>):<fpage>69</fpage>–<lpage>75</lpage>. Epub 1998/05/08. <pub-id pub-id-type="doi">10.1006/geno.1998.5213</pub-id>
.<pub-id pub-id-type="pmid">9570950</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref025">
<label>25</label>
<mixed-citation publication-type="journal">
<name><surname>Huang</surname><given-names>N</given-names></name>, <name><surname>Miller</surname><given-names>WL</given-names></name>. <article-title>Cloning of factors related to HIV-inducible LBP proteins that regulate steroidogenic factor-1-independent human placental transcription of the cholesterol side-chain cleavage enzyme, P450scc</article-title>. <source/>The Journal of biological chemistry. <year>2000</year>;<volume>275</volume>(<issue>4</issue>):<fpage>2852</fpage>–<lpage>8</lpage>. Epub 2000/01/25. .<pub-id pub-id-type="pmid">10644752</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref026">
<label>26</label>
<mixed-citation publication-type="journal">
<name><surname>Fluck</surname><given-names>CE</given-names></name>, <name><surname>Miller</surname><given-names>WL</given-names></name>. <article-title>GATA-4 and GATA-6 modulate tissue-specific transcription of the human gene for P450c17 by direct interaction with Sp1</article-title>. <source/>Mol Endocrinol. <year>2004</year>;<volume>18</volume>(<issue>5</issue>):<fpage>1144</fpage>–<lpage>57</lpage>. Epub 2004/02/28. <pub-id pub-id-type="doi">10.1210/me.2003-0342</pub-id>
.<pub-id pub-id-type="pmid">14988427</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref027">
<label>27</label>
<mixed-citation publication-type="journal">
<name><surname>Adzhubei</surname><given-names>IA</given-names></name>, <name><surname>Schmidt</surname><given-names>S</given-names></name>, <name><surname>Peshkin</surname><given-names>L</given-names></name>, <name><surname>Ramensky</surname><given-names>VE</given-names></name>, <name><surname>Gerasimova</surname><given-names>A</given-names></name>, <name><surname>Bork</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>A method and server for predicting damaging missense mutations</article-title>. <source/>Nature methods. <year>2010</year>;<volume>7</volume>(<issue>4</issue>):<fpage>248</fpage>–<lpage>9</lpage>. Epub 2010/04/01. <pub-id pub-id-type="doi">10.1038/nmeth0410-248</pub-id>
<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref028">
<label>28</label>
<mixed-citation publication-type="journal">
<name><surname>Bartsch</surname><given-names>O</given-names></name>, <name><surname>Kress</surname><given-names>W</given-names></name>, <name><surname>Wagner</surname><given-names>A</given-names></name>, <name><surname>Seemanova</surname><given-names>E</given-names></name>. <article-title>The novel contiguous gene syndrome of myotubular myopathy (MTM1), male hypogenitalism and deletion in Xq28:report of the first familial case</article-title>. <source/>Cytogenetics and cell genetics. <year>1999</year>;<volume>85</volume>(<issue>3–4</issue>):<fpage>310</fpage>–<lpage>4</lpage>. Epub 1999/08/18. 15284. .<pub-id pub-id-type="pmid">10449925</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref029">
<label>29</label>
<mixed-citation publication-type="journal">
<name><surname>Tsai</surname><given-names>TC</given-names></name>, <name><surname>Horinouchi</surname><given-names>H</given-names></name>, <name><surname>Noguchi</surname><given-names>S</given-names></name>, <name><surname>Minami</surname><given-names>N</given-names></name>, <name><surname>Murayama</surname><given-names>K</given-names></name>, <name><surname>Hayashi</surname><given-names>YK</given-names></name>, <etal>et al</etal>
<article-title>Characterization of MTM1 mutations in 31 Japanese families with myotubular myopathy, including a patient carrying 240 kb deletion in Xq28 without male hypogenitalism</article-title>. <source/>Neuromuscular disorders: NMD. <year>2005</year>;<volume>15</volume>(<issue>3</issue>):<fpage>245</fpage>–<lpage>52</lpage>. Epub 2005/02/24. <pub-id pub-id-type="doi">10.1016/j.nmd.2004.12.005</pub-id>
.<pub-id pub-id-type="pmid">15725586</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref030">
<label>30</label>
<mixed-citation publication-type="journal">
<name><surname>Oliveira</surname><given-names>J</given-names></name>, <name><surname>Oliveira</surname><given-names>ME</given-names></name>, <name><surname>Kress</surname><given-names>W</given-names></name>, <name><surname>Taipa</surname><given-names>R</given-names></name>, <name><surname>Pires</surname><given-names>MM</given-names></name>, <name><surname>Hilbert</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Expanding the MTM1 mutational spectrum: novel variants including the first multi-exonic duplication and development of a locus-specific database</article-title>. <source/>European journal of human genetics: EJHG. <year>2013</year>;<volume>21</volume>(<issue>5</issue>):<fpage>540</fpage>–<lpage>9</lpage>. Epub 2012/09/13. <pub-id pub-id-type="doi">10.1038/ejhg.2012.201</pub-id>
<pub-id pub-id-type="pmid">22968136</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref031">
<label>31</label>
<mixed-citation publication-type="journal">
<name><surname>Lim</surname><given-names>ET</given-names></name>, <name><surname>Raychaudhuri</surname><given-names>S</given-names></name>, <name><surname>Sanders</surname><given-names>SJ</given-names></name>, <name><surname>Stevens</surname><given-names>C</given-names></name>, <name><surname>Sabo</surname><given-names>A</given-names></name>, <name><surname>MacArthur</surname><given-names>DG</given-names></name>, <etal>et al</etal>
<article-title>Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders</article-title>. <source/>Neuron. <year>2013</year>;<volume>77</volume>(<issue>2</issue>):<fpage>235</fpage>–<lpage>42</lpage>. Epub 2013/01/29. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.12.029</pub-id>
<pub-id pub-id-type="pmid">23352160</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref032">
<label>32</label>
<mixed-citation publication-type="journal">
<name><surname>O'Shaughnessy</surname><given-names>PJ</given-names></name>, <name><surname>Baker</surname><given-names>PJ</given-names></name>, <name><surname>Monteiro</surname><given-names>A</given-names></name>, <name><surname>Cassie</surname><given-names>S</given-names></name>, <name><surname>Bhattacharya</surname><given-names>S</given-names></name>, <name><surname>Fowler</surname><given-names>PA</given-names></name>. <article-title>Developmental changes in human fetal testicular cell numbers and messenger ribonucleic acid levels during the second trimester</article-title>. <source/>The Journal of clinical endocrinology and metabolism. <year>2007</year>;<volume>92</volume>(<issue>12</issue>):<fpage>4792</fpage>–<lpage>801</lpage>. Epub 2007/09/13. <pub-id pub-id-type="doi">10.1210/jc.2007-1690</pub-id>
.<pub-id pub-id-type="pmid">17848411</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref033">
<label>33</label>
<mixed-citation publication-type="journal">
<name><surname>Ogata</surname><given-names>T</given-names></name>, <name><surname>Sano</surname><given-names>S</given-names></name>, <name><surname>Nagata</surname><given-names>E</given-names></name>, <name><surname>Kato</surname><given-names>F</given-names></name>, <name><surname>Fukami</surname><given-names>M</given-names></name>. <article-title>MAMLD1 and 46,XY disorders of sex development</article-title>. <source/>Seminars in reproductive medicine. <year>2012</year>;<volume>30</volume>(<issue>5</issue>):<fpage>410</fpage>–<lpage>6</lpage>. Epub 2012/10/10. <pub-id pub-id-type="doi">10.1055/s-0032-1324725</pub-id>
.<pub-id pub-id-type="pmid">23044878</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref034">
<label>34</label>
<mixed-citation publication-type="journal">
<name><surname>Baxter</surname><given-names>RM</given-names></name>, <name><surname>Vilain</surname><given-names>E</given-names></name>. <article-title>Translational genetics for diagnosis of human disorders of sex development</article-title>. <source/>Annu Rev Genomics Hum Genet. <year>2013</year>;<volume>14</volume>:<fpage>371</fpage>–<lpage>92</lpage>. Epub 2013/07/24. <pub-id pub-id-type="doi">10.1146/annurev-genom-091212-153417</pub-id>
<pub-id pub-id-type="pmid">23875799</pub-id></mixed-citation>
</ref>
<ref id="pone.0142831.ref035">
<label>35</label>
<mixed-citation publication-type="journal">
<name><surname>Kon</surname><given-names>M</given-names></name>, <name><surname>Fukami</surname><given-names>M</given-names></name>. <article-title>Submicroscopic copy-number variations associated with 46,XY disorders of sex development</article-title>. <source/>Molecular and Cellular Pediatrics. <year>2015</year>;<volume>2</volume>(<issue>7</issue>). <pub-id pub-id-type="doi">10.1186/s40348-015-0018-2</pub-id>
</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>